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ABSTRACT

Previous studies in Dr. Yang’s laboratory have established a grafting, design, and
subdomain approach in order to investigate the properties behind Ca2+-binding sites located in
Ca2+-binding proteins by employing engineered proteins. These approaches have not only enabled
us to isolate Ca2+-binding sites and obtain their Ca2+-binding affinities, but also to investigate
conformational changes and cooperativity effects upon Ca2+ binding.
The focus of my thesis pertains to optimizing the expression and purification of engineered
proteins with tailored functions. Proteins were expressed in E. coli using different cell strains,
vectors, temperatures, and inducer concentrations. After rigorous expression optimization
procedures, proteins were further purified using chromatographic and/or refolding techniques.
Expression and purification optimization of proteins is essential for further analyses, since the

techniques used for these studies require high protein concentrations and purity. Evaluated proteins
had yields between 5-70 mg/L and purities of 80-90% as confirmed by SDS-PAGE
electrophoresis.
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1.
1.1

INTRODUCTION

Ca2+-binding proteins and their properties
Calcium (Ca2+) is classified as an alkaline-earth metal and is one of the most abundant

metallic elements on earth. It is involved in the regulation of numerous important cellular
signaling pathways and biological processes in living organisms [1, 2]. In the Ca2+-dependent
signal pathways, Ca2+ binding usually results in large conformational changes which allow
proteins to interact with downstream partners or other target molecules.
Ca2+ concentrations vary more than 1000-fold in intracellular and extracellular
environments and that is why Ca2+-binding proteins usually have different Ca2+-binding affinities
depending upon their functional locations [2-4]. These proteins function by experiencing Ca2+
induced conformational changes whereby Ca2+ influxes are translated into metabolic responses
[5]. For example, eukaryotic cells in a resting state can present a cytoplasmic Ca2+ ion level
between 10-7-10-6 M, which can be considered quite low compared to an extracellular
concentration of 10-3 M (Figure 1) [4, 6]. It is important to mention that external stimuli such as
hormonal signals can change the cytoplasmic Ca2+ ion level to an activated state of ~10-6 M [4,
6]. Thus, a significant number of intracellular and extracellular Ca2+-binding proteins play
essential roles in maintaining a proper distribution of Ca2+ concentrations [3]. These Ca2+binding proteins have important intracellular and extracellular functions. For example,
intracellular Ca2+-binding proteins are important in Ca2+ buffer and transport systems, activation
of enzymes, metabolism, gene expression, apoptosis, and Ca2+ storage just to mention a few
intracellular functions (Figure 1) [2-4]. Additionally, extracellular Ca2+-binding proteins are
important in neurite extension, chemotactic and hormone activity and they are important
extracellular matrix components (Figure 1) [2-4].
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Figure 1. Intracellular and extracellular Ca2+ concentrations and important functions of Ca2+binding proteins (CaBPs) [2-4].
For example, calmodulin (CaM) is an extremely important and well studied intracellular
Ca2+-binding protein that belongs to the large EF-hand family. A typical EF-hand protein
consists of two or more α–helices oriented ~90o with respect to each other, and a loop around the
Ca2+ ion in a helix-loop-helix formation [5, 7-9]. CaM contains four EF-hand motifs, and other
EF-hand proteins may include two to eight EF-hand motifs [5, 7]. EF-hand proteins usually bind

3
to Ca2+ in a pentagonal bipyramidal arrangement with seven oxygen ligands (six of the ligands
from the protein’s side chains of Asp, Asn, Glu, and/or the main chain, and one from a water
molecule) [5, 8]. EF-hand proteins have similar primary sequences and secondary structures but
their cellular functions and the way they respond to Ca2+ are enormously diverse.
Non-EF-hand proteins, such as cell adhesion molecules, transmembrane proteins, and
receptors like the Ca2+-sensing receptor (CaSR) typically do not possess conserved Ca2+-binding
loops and helices, but they do possess Ca2+-binding sites located at linker regions between
domains or on extracellular domains [9]. For example, the CaSR senses extracellular Ca2+
concentrations and responds to those changes by modulating multiple intracellular signaling
pathways through a series of Ca2+-binding sites located in the extracellular domain (ECD) of this
receptor [10]. This important receptor is expressed in a great number of tissues and it is
associated with a large number of diseases including hypercalcaemia, hypocalcaemia,
hypoparathyroidism, and hyperparathyroidism [11].
It is possible to find a great number of solved structures of Ca2+-binding proteins, but
many details related to Ca2+-protein interactions and processes in which these special proteins
achieve their Ca2+-binding affinities are still unknown [8, 9, 12]. Ca2+-binding proteins are
characterized by having different Ca2+-binding sites that interact with each other as they sense
Ca2+. Commonly-used experiments and investigations have been performed in order to study the
total Ca2+ interaction with different proteins. Due to issues with cooperativity, efforts have been
made to investigate isolated Ca2+-binding sites either by grafting the sites onto scaffold proteins,
separating domains, or inactivating binding sites, but these approaches, may produce results in
the tested system that differ significantly from the intact protein, particularly with respect to
Ca2+-binding affinities [8, 9, 12].
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1.2

Creating engineered Ca2+-binding proteins
The first step in creating an engineered protein is to study in detail the chemical,

biological, physical, and structural properties of the potential host protein. Stability of the host
protein is an important characteristic because the protein must be able to tolerate mutations
and/or addition of amino acid sequences while retaining its natural conformation and
biochemical properties.
The development of engineered Ca2+-binding proteins by predicting Ca2+-binding sites and
further designing or grafting them into a host protein can be an excellent way to understand and
study Ca2+-protein interaction in more detail. However it is important to emphasize that the host
protein must retain its native structure after the Ca2+-binding site has been designed or grafted
and that the protein’s environment should not affect the Ca2+-binding properties [12].
Domain one of cluster of differentiation (CD2.D1) is a 99 residue long non-Ca2+-binding
protein that was chosen as the host protein for protein engineering [13, 14]. CD2.D1 exhibits
several characteristics that make it an attractive scaffold for engineering, including: easy
expression and purification; maintenance of its native folding state over a wide range of both pH
(pH 1.0-10.0) and salt concentrations (0-4 M); and previous data for over 40 mutations shown
not to produce significant deviations from its native fold [13, 14]. Also, well established X-ray
and NMR structures for human (Figure 2A) and rat CD2 (Figure 2B) have been reported
allowing biophysical analysis based on those results [15-18]. Therefore, the design of engineered
Ca2+-binding proteins using this protein is an excellent way to study Ca2+-binding affinity and
metal and Ca2+ selectivity by integrating Ca2+-binding sites into CD2.D1.
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A

B

Figure 2. Structure of human and rat CD2. (A) Ribbon drawing for human CD2 domains I and II
[17]. (B) Ribbon drawing for rat CD2 domain 1 [18].
1.3

Protein expression: E. coli as a protein producer
The bacterium Escherichia coli (E. coli) is the most widely studied prokaryotic organism

and most commonly used bacterium for protein production in laboratory and industrial scenarios.
It is a rod-shaped gram-negative bacterium containing a distinct surface layer composed of inner
and outer phospholipid membranes and a rigid peptidoglycan cell wall between these two layers
[19, 20]. This biochemical structure allows these gram-negative bacteria to adjust and adapt
themselves to different environments and especially to temperature changes, since they also have
the ability to physically change the diameter of their porins located on the cell membrane when
they sense environmental changes [20]. E. coli has been selected for different studies because it
is quite easy to grow in the laboratory and because its genetic mechanisms co-evolved along
with those of mammals. These microorganisms can be grown in the laboratory in liquid rich or
minimal media doubling in number about every 20-30 minutes depending upon the media
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nutrients, usually at a temperature of 37 oC, and they can also be grown as colonies on agar
plates containing nutrient medium and antibiotics to avoid contamination [19, 21].
Most bacteria reproduce via an asexual process called binary fission in which each cell
increases in size and divides into two cells [22]. During this process there is an orderly increase
in cellular structures and components, replication and segregation of the bacterial DNA, and
formation of a septum or cross wall which divides the cell into two progeny cells [22]. A
growing bacterial population doubles at regular intervals in an exponential way; but the
exponential growth is only part of the bacterial life cycle, and it does not represent the natural
pattern of growth of bacterial cultures [22].
Under optimum conditions, bacteria will increase in number until they either deplete the
nutrients in the medium or accumulate sufficient waste products to inhibit growth. Under these
conditions of saturation, the cells undergo a physiological change that allows for survival in the
absence of growth. This state is called stationary phase, where the number of cells in a culture
increases slowly, if at all. When stationary phase cells are diluted into fresh medium, they
undergo another physiological change and begin to divide at an exponential rate known as the
logarithmic or log phase. Most physiological experiments are conducted using rapidly dividing
log phase cultures. Cell growth can be measured by following the increase in absorption of a
culture at 600 nm using a spectrophotometer and checking the optical density (OD) at different
time periods. A culture with an absorbance of 1.0 at 600 nm contains approximately 2 x 108
cells/mL [22].
1.3.1

Factors that affect protein expression
Several factors may affect protein expression. For instance, selection of a proper cell

strain is an essential factor that needs to be considered during bacterial transformation and
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expression. This is a critical factor because protein expression can be strongly influenced by the
way these cell strains respond at different expression temperatures and inducer amounts.
Protein expression in E. coli can follow two paths, where the protein is either expressed
in a soluble, well-folded form or as inclusion bodies or similar insoluble aggregates (Figure 3).
These inclusion bodies are usually inactive misfolded proteins that were formed due to overexpression. [23]. It is important to mention that sometimes certain proteins can be purified from
inclusion bodies and therefore, inclusion body formation is desired and sometimes the best way
to obtain pure and functional proteins [24].

9
9
9

9
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Figure 3. E. coli and the production of soluble or insoluble proteins and two strategies to treat
and/or prevent inclusion body formation [25].
Experimental methods can be designed and modified to avoid inclusion bodies formation.
First, a refolding strategy can be developed where denaturants are used to initially solubilize and
unfold the protein, followed by removal of the denaturant to allow Domain 1 of cluster of
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differentiation 2 the protein to refold into the native and active conformation (Figure 3) [25].
Another option is to modify the expression conditions in order to obtain soluble proteins. We can
therefore test various temperatures, cell strains, and/or media conditions without changing the
target sequence or we can also engineer the target by expressing fragments or making changes to
the target sequence using fusion technology (Figure 3) [25]. Low expression temperature and
low induction concentrations usually increases protein’s solubility [25]. For example,
temperatures around 30 oC activate a great number of E. coli chaperones stabilizing and favoring
correct folding [23].
1.3.1.1 Protein expression using different cell strains
There are a great variety of cell strains that can be used in order to express proteins in E.
coli. The most widely used cell strain is BL21 which does not encode Ion, ompT, and ompP
proteases minimizing protein degradation during purification [19, 26]. There are different strains
within BL21. For example, BL21(DE3) contains a T7 RNA polymerase gene that is integrated
into the genome and that is under control of the lacUV5 promoter, which is a lactose analog
IPTG inducible system. The difference between BL21(DE3) and BL21(DE3)pLysS is that the
pLysS strain has a plasmid encoding a T7 lysozyme gene that allows the expression of more
toxic proteins in greater amounts since that gene is a natural inhibitor of T7 RNA polymerase
and therefore, protein expression is tightly regulated [27]. Moreover, the cell wall lysis in the
purification step is greatly enhanced in pLysS strain compared to DE3 because the lysozyme
comes out and lyses the cells in addition to the method of cell disruption (French press or
sonication).
Tuner is another strain that can be used for protein expression. Tuner strains are lacZY
deletion mutants of BL21 which enable adjustable levels of protein expression throughout all
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cells in a culture by allowing precise IPTG control [27]. Therefore, IPTG induction can occur in
a true concentration-dependent fashion that is uniform throughout the culture and the expression
can be regulated from very low expression levels up to highly induced expression levels [27].
Rosetta strains are derived from BL21 lacZY and tuner strains but they carry a pRARE
derived plasmid that encodes several “rare” E. coli tRNA genes that can be encoded by a
chloramphenicol resistant plasmid [27]. Some of the rare codon genes are AGG/AGA (arginine),
AUA (isolucine), and CCC (proline) [27]. Therefore, these strains are designed to increase the
expression of heterologous proteins whose genes encode numerous rare E. coli codons.
Expression of these proteins can be dramatically increased when the level of rare tRNA is
increased within the host.
Origami strains have mutations in both the thioredoxin reductase (trxB) and glutathione
reductase (gor) genes, which enhance disulfide bond formation in the cytoplasm. These strains
are selectable on kanamycin, tetracycline, ampicillin, and chloramphenicol. OrigamiB is a
derivative of origami and tuner strains and it contains trxB and gor mutations and it facilitates a
precise IPTG control during protein expression [28].
It is possible that problems associated with low expression, toxicity or protein solubility
may be mitigated by protein expression optimization using different cell strains. For general
expression it might be useful to use BL21(DE3) but if we need to work with a toxic protein it
might be better to utilize BL21(DE3)pLysS. On the other hand, if we are working with an
insoluble protein tuner(DE3)pLacI might be the best way to express the target protein. Protein’s
low expression levels might be enhanced by using rosetta(DE3)pLysS or origamiB(DE3)pLysS.
A brief description and applications of five cell strains are summarized in Table 1 and a more
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detailed table that was modified from Novagen with the most commonly used cell strains in our
lab can be observed in Table 2 [28].
Table 1. Common applications of five E. coli cell strains
Cell Strain

Comments

General
Expression

BL21(DE3)

T7-based expression upon IPTG induction.

Toxic
Protein

BL21(DE3)
pLysS

The pLysS plasmid produces T7 lysozyme to
reduce basal level expression of the gene of
interest.

Insoluble
Protein

Tuner(DE3)
pLacI

Contains a mutation in the lac permease (lacZY)
gene. This enables adjustment of protein
expression by using different IPTG
concentrations.

Low
Expression

Rosetta(DE3)
pLysS

BL21(DE3)pLysS

Rosetta(DE3)pLysS

Rosetta-gami(DE3)pLysS

OrigamiB(DE3)pLysS

Tuner(DE3)pLacI

Contains mutations in thioredoxin reductase and
glutathione reductase genes, which enhances
disulfide bond formation in the cytoplasm

BL21(DE3)

OrigamiB(DE3)
pLysS

They supply tRNAs rarely used in E. coli
providing a “universal” translation.

BL21 - lacks of ompT (outer membrane protein T) membrane and cytoplasmic Lon proteases

X

X

X

X

X

X

DE3 - host carries a chromosomal copy of the T7 RNA polymerase gene under control of the
lacUV5 promoter

X

X

X

X

X

X

X

X

X

X

Description

Cell strain

Table 2. Description of cell strains employed in this thesis

pLysS - provides T7 lysozyme (reduce basal expression of target genes)
Carries lacIq for overexpression of lac represor protein (suppresses basal expression from
promoters)

X

Lacks trxB, thioredoxin reductase (facilitates disulfide bond formation in cytoplasm)

X

X

Lacks gor, glutathione reductase (facilitates disulfide bond formation in cytoplasm)

X

X

Lacks lacY (providing a homogeneous uptake of IPTG into all cells in the population)

X

X

Overproduces lacI (suppress basal transcription of target genes controlled by lac operators)

X

Provides tRNAs for mammalian codons that rarely occur in E. coli
Chloramphenicol resistance

X

X

X

X

X

X

X

Kanamycin resistance

X

X

Tetracycline resistance

X

X

X
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Temperature and inducer concentrations vary between cell strains and protein expression
can be highly affected by these factors. Protein solubility is actually enhanced when proteins are
expressed at lower temperatures (30 oC, 25 oC, or lower), because these low temperatures slow
down cells growth rate during bacterial expression, help to avoid formation of hydrophobic
interactions, and proteases activity is highly reduced [20, 27]. Additionally, chromophore
formation of certain proteins is often achieved at low temperatures.
1.4

Protein purification and its aims
Purification may be preparative or analytical. The aims in a preparative purification are to

produce a relatively large quantity of purified proteins for subsequent use. Examples include the
preparation of commercial products such as enzymes (e.g. lactase), nutritional proteins (e.g. soy
protein isolate), and certain biopharmaceuticals (e.g. insulin) [29, 30]. The aim in an analytical
purification is to produce a relatively small amount of protein for a variety of research or
analytical purposes, including identification, quantification, and studies of the protein's structure,
post-translational modifications and function [29]. If the protein is present in low amounts, a
recombinant DNA technology can be used in order to develop cells that will produce large
quantities of the desired protein, and in that way, create an expression system.
Additionally, an analytical purification generally utilizes certain protein properties in
order to separate proteins, and depending on the source, purified proteins used for analytical
purposes have to be brought into solution by breaking the tissue or cells containing them. There
are several methods for achieving this including, repeated freezing and thawing, sonication,
homogenization by high pressure, or permeabilization by organic solvents. The method of choice
depends on the relative fragility of the protein and the robustness of the cells. After the
extraction process, soluble proteins can be separated from cell membranes, DNA, and other
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undesired components by centrifugation. The extraction process removes proteases, which will
start digesting proteins in solution. If the protein is sensitive to proteolysis, it is usually desirable
to proceed quickly, and keep the extract cooled to slow down proteolysis. Usually a protein
purification protocol contains one or more chromatographic steps. The basic procedure in
chromatography is to move the solution containing the protein through a column packed with
various materials. Different proteins interact differently with the column material, and can thus
be separated by the time required to pass the column or the conditions required to elute the
protein from the column.
1.4.1

Commonly used purification techniques: separation based on chemistry
A great number of chromatographic methods for molecules separation involve a chemical

interaction between the molecules of interest and the separation medium. These chemical
interactions include dispersion forces, electrostatic dipole interactions, electron-donor acceptor
forces, and covalent bonds formations. Dispersion force interactions are caused by induced
dipole-induced dipole interactions and are therefore classified as non-specific interactions.
Electrostatic dipole interactions are related to orientation of permanent dipoles and/or the
interaction between a permanent dipole and an induced dipole. Electron donor acceptor
interactions include overlap of electron clouds, sharing of lone electrons, and the overlap of
orbitals to form bonds. Covalent bond formation involves a transition from intermolecular to
intramolecular forces and it is somewhat related to an electron donor-acceptor interaction [2931].
1.4.1.1 Ion exchange chromatography
Ion exchange chromatography separates compounds according to the nature and degree
of their ionic charge. The column to be used is selected according to its type and strength of
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charge. There are two types of ion exchange chromatography. One is cation exchange in which
the resins have a negative charge and are used to separate positively charged molecules. The
second one is anion exchange in which the resins have a positive charge and are used to retain
and separate negatively charged compounds (Figure 4) [29, 32]. Before the separation begins a
buffer is pumped through the column to equilibrate the opposing charged ions. Upon injection of
the sample, solute molecules will exchange with the buffer ions as each competes for the binding
sites on the resin. The length of retention for each solute depends upon the strength of its charge.
The most weakly charged compounds will elute first, followed by those with successively
stronger charges. Because of the nature of the separating mechanism, pH, buffer type, buffer
concentration, and temperature all play important roles in controlling the separation [29, 32].

Figure 4. The principle of ion exchange chromatography (anion exchange) [32].
1.4.1.2 Affinity chromatography
Affinity chromatography is a method of separating biochemical mixtures, based on a
highly specific biologic interaction, such as that between antigen and antibody, enzyme and
substrate, or receptor and ligand [31, 33]. This chromatographic technique separates proteins on
the basis of a reversible interaction between a protein and a specific ligand attached to a
chromatographic matrix [33]. Therefore, the target protein or molecule is specifically and
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reversibly bound to a complementary binding substance (affinity ligand) to then be desorbed
from the stationary phase (Figure 5) [32].

Figure 5. The principle of affinity chromatography [32].
This chromatography technique allows purification of proteins that have fusion tags, such
as glutathione S-transferase (GST), polyhistidine (6x-his), and/or thioredoxin (thx) tags. The
sample is applied under conditions that favor specific binding. Unbound material is washed
away, and the bound target protein is recovered by changing conditions to those favoring
desorption [32, 33]. Desorption is performed specifically using a competitive ligand or by using
chemicals or conditions that can break bonds between the fusion tags and the target protein.
Proteins are then collected, dialyzed in the desired buffer, and if necessary further purified using
other chromatographic techniques.
1.4.1.3 Hydrophobic interaction chromatography
This type of technique separates biological macromolecules like proteins based on their
hydrophobic surface (Figure 6) [32]. Its separation principle is still not well understood since
most of the protein’s tertiary structure hides the hydrophobic core and exposes the polar
residues, but some proteins still present hydrophobic areas or patches on the surface [30-33].
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This is a very powerful technique that allows the separation of closely related proteins and it can
accomplish separations that ion-exchange or affinity chromatography can not accomplish.

Hydrophobic region

Figure 6. The principle of hydrophobic interaction chromatography [32].
1.4.1.4 Protein refolding and denaturant agents
Proteins can form inclusion bodies or inactive aggregates during the expression procedure
and in some circumstances these inactive aggregates can be useful and advantageous in protein
purification. The first step in protein purification using a refolding method is to isolate inclusion
bodies and then use detergents and denaturants, such as urea, arginine, and/or guanidinium ions
in order to completely unfold the protein (Figure 7). The following steps involve the removal of
detergents and denaturants using dialysis or dilution strategies in order to slowly refold the
protein into its native and active conformation. Sometimes, it is also necessary to further utilize
other chromatographic techniques, such as ion exchange or affinity chromatography in order to
further purify the protein.

Urea

Arginine

Figure 7. Chemical structures of three commonly used denaturants.

Guanidinium ion
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This purification technique has its advantages and disadvantages. Some disadvantages are
that it is time-consuming and there is no guarantee that the proteins will refold to its native
conformation without losing activity and stability [26]. However, this purification strategy has
been successfully demonstrated with small proteins, resulting in high yields at a low cost [26].
Additionally, insoluble aggregates are often protected against degradation by reducing the ability
of proteases to damage the proteins. Therefore, protein refolding can be an excellent technique to
purify proteins that were expressed as insoluble aggregates.
One of the most commonly used denaturants in protein refolding is urea or carbamide.
This water-soluble organic compound, which can form up to eight hydrogen bonds (Figure 7)
[34], has been widely used to solubilize proteins and especially inclusion bodies since it
hydrogen-bonds to water [35]. The molecular basis for urea’s denaturation abilities is still
unknown, but it has been suggested that this compound can have a direct or an indirect effect in
protein’s stability. Thus, urea might be able to weaken protein’s structure and stability by
disrupting intramolecular hydrogen-bonds upon direct interaction with the protein [36, 37]. Or it
might also indirectly affect protein’s stability by altering the solvent environment and in that way
facilitate exposure of hydrophobic residues [37]. An additional possibility that might explain
urea’s effect in protein’s stability is that this effect might be a combination of protein-urea and
solvent-urea interaction.
1.4.2

Detection of impurities using SDS-PAGE electrophoresis
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) is an excellent

and relatively rapid way to determine a protein’s molecular mass and at the same time analyze its
purity and expression level since this technique separates proteins according to size [29]. This
technique has been widely used to optimize purification steps and strategies in order to increase
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protein’s purity, expression, and stability [29]. The sample to be analyzed is mixed with a
detergent (SDS) in order to denature the protein’s secondary and tertiary structures, and at the
same time apply a negative charge to the proteins since SDS is an anionic detergent containing a
sulfate group. Therefore, proteins will be in a primary structure and they will be negatively
charged allowing them to migrate toward the positive pole when an electric field is employed.
Denatured samples will pass through a large pore 4% polyacrylamide gel (stacking gel) in order
to have a starting point where all the proteins are concentrated to then pass through a small pore
3-30% polyacrylamide gel (resolving gel) containing different pore sizes and where smaller
proteins will be able to go further down the gel whereas the larger proteins will stay on the top.
1.5

Objectives of this study
The main objectives of this study are to optimize the expression and purification of

engineered Ca2+-binding proteins. Protein’s expression and purification are essential steps
necessary to obtain proteins with high purity and yields. The successful optimization of these
two important steps will allow us to obtain high quality and quantity proteins with the least
possible amount of time and effort. These proteins will be used to perform future experiments
(such as, metal binding studies, nuclear magnetic resonance (NMR), mass spectroscopy (MS),
circular dichroism (CD), and titrations) in order to test their conformation and metal binding
affinity and selectivity.
1.6

Overview
The research in this thesis is organized in the following way: In Chapter 1, I have introduced

Ca2+-binding proteins and some of their most important properties and functions in extracellular
and intracellular environments. I have also introduced important concepts related to the
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expression and purification, such as factors that affect protein expression in E. coli and important
purification techniques that are commonly used to purify proteins.
In Chapter 2, materials and methods used to express and purify engineered Ca2+-binding
proteins are presented. The expression of some of these proteins was performed in two different
media and four chromatographic techniques were used in order to purify engineered proteins
depending upon the protein’s physiochemical and conformational characteristics. The remaining
chapters will focus on the expression and purification of engineered Ca2+-binding proteins that
were developed using either a grafting, subdomain, and/or design approach.
Chapter 3 introduces the grafting approach and how two host proteins, CD2 and EGFP, were
used to insert Ca2+-binding motifs to study metal-binding affinity, selectivity, and the creation of
new EGFP-based Ca2+ sensors. This chapter presents the expression of CD2-WT and EGFP-WT
and their variants, and it also includes protein purification using affinity (GST-tag or His-tag)
and ion exchange chromatography.
Chapter 4 presents a brief relationship between CaM and the grafting approach. This chapter
will mainly focus on the expression and purification of this important intracellular Ca2+-binding
protein.
Chapter 5 relates the grafting approach with the subdomain approach and how these
approaches were used in order to study the CaSR and its Ca2+-binding affinity and selectivity.
This chapter presents the expression and purification of two engineered Ca2+-binding sites that
were grafted into CD2.D1 and purified using affinity (GST-tag) and ion exchange
chromatography. It also includes the expression optimization of subdomain 1, 2, and 3 of the
ECD of the CaSR and their purification employing affinity (6x-his-tag) chromatography for
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subdomain 1 and 2, and a refolding method for subdomain 3. It will also discuss recent studies
and accomplishments in the expression and purification of the ECD of the CaSR.
Chapter 6 introduces the design approach, the expression and purification of tag-less
proteins CD2.7E15 and a variant using a refolding method and their applications as MRI contrast
agents.
Chapter 7 is a concise summary of major conclusions and the significance of this thesis.
A summary of all studied engineered proteins by chapter and information related to their
expression and purification can be observed in Table 3.
Table 3. Summary of engineered proteins studied by chapter
Chapter

Engineered
Protein

Approach

Fusion
Tag

Vector

Cell
Strain

Purification
Technique

3

CD2.STIM1
CD2.STIM1.Mut1
CD2.Rub.Ca

Grafting
Grafting
Grafting

GST
GST
GST

pGEX-2T
pGEX-2T
pGEX-2T

BL21(DE3)
BL21(DE3)
BL21(DE3)

AC and IEC
AC and IEC
n/a

EGFP.WT
EGFP.EF.172

n/a
Grafting

6x-His
6x-His

pET28a
pET28a

BL21(DE3)
BL21(DE3)

AC
AC

n/a

n/a

pET20b

BL21(DE3)

HIC

Grafting
Grafting
Grafting

GST
GST
GST

pGEX-2T
pGEX-2T
pGEX-2T

BL21(DE3)
BL21(DE3)
BL21(DE3)

AC and IEC
AC and IEC
AC and IEC

Subdomain
Subdomain
Subdomain

6x-His
6x-His
6x-His

pRSETa
pRSETa
pRSETa

Rosetta(DE3)pLysS
Rosetta(DE3)pLysS
Tuner(DE3)pLacI

AC
AC
Refolding and AC

n/a

6x-His

pRSETa

Rosetta-gami(DE3)pLysS
OrigamiB(DE3)pLysS

AC

Design
Design

n/a
n/a

pET20b
pET20b

Tuner(DE3)pLacI
Tuner(DE3)pLacI

Refolding and IEC
Refolding and IEC

4

CaM.WT

5

CD2.CaSR.Site3
CD2.CaSR.Site5
CD2.CaSR.Mutants
Subdomain 1
Subdomain 2
Subdomain 3
ECD

6

CD2.7E15
CD2.7E15.52I
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2.
2.1

MATERIAL AND METHODS

Cloning and transformation
Engineered proteins were cloned by standard PCR reactions by Dr. Yun Huang [38] and

Dr. Yubin Zhou [39] and details can be found in their PhD dissertations. The competent cells
used for the transformation procedures were BL21(DE3), BL21(DE3)pLysS, Tuner(DE3)pLacI,
Rosetta-gami(DE3)pLysS, OrigamiB(DE3)pLysS and/or Rosetta(DE3)pLysS. The antibiotics
used were ampicillin, kanamycin chloramphenacol, and/or tetracycline. To begin, 50 μL of the
competent cell were added into labeled tubes, followed by 0.5-1.0 μL of DNA. The tubes were
then placed on ice for 30 minutes, then in 42 oC water bath for exactly 90 seconds to allow the
DNA transfer into cell. Following this heat shock, samples were returned to the ice bucket for 2
minutes. Next, 50 μL of Luria-Bertani (LB) media was added to the tubes and they were then
placed in an incubator for 30 minutes at 37 oC. After 30 minutes, 50 μL of the cell culture were
added drop wise to a labeled agar plate, and streaked across the agar surface using a sterile
triangle. One additional plate was streaked (without DNA) as a control and both were placed at
37 oC overnight with the agar side of the plate facing up.
2.2
2.2.1

Protein expression
Luria-Bertani (LB) media
For overnight inoculation, a single and healthy clone was removed from a previously

transformed agar plate using an inoculation loop. The loop was inserted and stirred to release the
clone into a 1 L flask containing 500 mL LB media (10 g/L peptone from casein, 5 g/L yeast
extract, and 10 g/L NaCl) and 100 mg/L ampicillin or 30 mg/L kanamycin. The flask was then
placed in the shaker to incubate overnight at 37 oC at a speed of 220-230 rpm.
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For the expression of engineered proteins, 50 mL of observable cell growth grown
overnight was placed into a 4 L flask containing 1 L LB media. Next, either 1000 μL of
ampicillin (100 mg/L) or 600 μL of 50 mg/mL kanamycin were added for a final concentration
of 0.03 mg/mL and the flask was placed in the shaker at 37 oC. The optical density (OD) was
checked at regular intervals to evaluate cell growth using a Shimadzu UV-1601 PharmaSpec
UV-Vis spectrophotometer with UV Probe software (Shimadzu North America, Columbia, MD).
When the OD reached approximately 0.6-0.8, cells were induced with 100-500 μL isopropyl ß–
D-1-thiogalactopyranoside (IPTG) which is an effective inducer in the concentration range of
0.1-1.5 mM. Cells were collected the same day they were expressed at 37 oC or if they were
expressed at lower temperatures (25 oC or 30 oC) cells were allowed to grow overnight with
agitation and collected the following day. Cells were collected using high speed centrifugation
(7,000 rpm) for 20 minutes and stored at -20 oC (Figure 8).

Transformation

Shake overnight
at 37oC

500 mL LB
500 μl ampicillin

50 mL LB

1 L LB
1 mL ampicillin

IPTG

Centrifuge

Collect pellet and store at
low temperature

Shake at 37°C to
desired OD600 nm

When OD600 nm ~ 2.000
collect cell pellet

Figure 8. Diagram illustrating protein expression in E. coli.

Induce with IPTG when
OD600 nm is ~ 0.600
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2.2.2

Labeled 15N minimal media
Labeled

15

N minimal media was prepared using the following chemicals: K2HPO4·3H2O

(10.4 g/L), KH2PO4 (4.4 g/L) MgSO47H2O (0.05 g/L), (NH4)Fe(SO4)2·6H2O (0.007 g/L), 20%
glucose, and 20%
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NH4Cl. The expression procedure using minimal media is similar to that

explained earlier for LB media (Figure 8). The only difference is the procedure used in the
inoculation step. It was necessary to inoculate 10 mL of LB media, 10 μL ampicillin, and a
healthy individual clone from an agar plate that contained 3% glucose in three to four different
50 ml plastic tubes for at least 8 hours. The best growing cultures were then transferred to a 1 L
minimal media flask until the OD reached a 0.6 value. Cells were then induced with 150 μl IPTG
and temperature was reduced to 25 oC overnight. The expressed and further purified proteins
included 15N labeled atoms that were used in NMR studies.
2.3

Protein purification
Engineered proteins were originated using a grafting, a subdomain, or a design approach.

Some of these proteins had fusion tags which helped for a successful expression and purification
and other proteins were expressed and purified as wild type proteins for use as controls in future
experiments.
All of the engineered proteins that were grafted into CD2.D1 contained a GST-tag
(pGEX-2T) and they were purified using affinity and ion exchange chromatography, whereas,
those proteins that were grafted into EGFP contained a 6x-his-tag (pET28a) and were purified
using nickel-sepharose affinity chromatography. Proteins generated from the subdomain
approach also contained a 6x-his-tag (pRSETa). Subdomain 1 and 2 were therefore purified
using nickel-sepharose affinity chromatography. However, an additional refolding technique was
utilized to purify subdomain 3. Proteins that were generated using a design approach were tag-
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less proteins (pET20b) and they were therefore purified using a refolding technique followed by
ion exchange chromatography. CaM was another tag-less (pET20b) protein that was purified
using hydrophobic interaction chromatography. Refer to Table 3 in Chapter 1 for a complete
table that summarizes all the engineered proteins, fusion tags, vectors, and purification
technique(s) used.
2.3.1

Affinity and ion exchange chromatography (GST-tag)
A 2 L expression cell pellet was re-suspended in 35-50 mL lysis buffer (1% sacosine and

1 mM EDTA in PBS, pH 7.4) and 1 M DTT was added to the solution to a final concentration of
5 mM. The resulting solution was subjected to sonication (Branson 450 Sonifier) 7-8 times for
30 seconds with 1-2 minute intervals between sonications in order to avoid protein degradation
due to heat produced by the sonicator’s sound waves.
The solution was then centrifuged at 17,000 rpm for 40 minutes (S34 rotor). The
supernatant was subsequently filtered with a 0.45 μm filter (Whatman, Florham Park, NJ) and
the filtered supernatant was then poured in glutathione (GST) agarose beads (GE healthcare)
affinity columns in order to start protein binding. The flow through was repetitively passed over
the column 3-5 times for further binding. The affinity columns were washed with 50 mL 1X PBS
buffer. A 2:5 BioRad protein assay is used to determine if the protein was bound to the GST
beads. If the binding was successful a color change was observed on a micro-plate reader from a
copper to a blue color. The protein was cleaved adding 20-40 μL per column of thrombin. The
cleavage was done overnight at 4 oC with agitation and for an additional 2-3 hours at room
temperature the following day. The columns were then washed with 20-50 mL 1X PBS buffer
per column and allowed to elute the protein. The BioRad protein assay was used to determine if
all the protein was eluted (Figure 9).
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Supernatant

Expression pellet was
dissolved in ~ 50 mL
lysis buffer

Cell pellet

Sonication or
French press

Protein binds to
the GST beads

PBS

Obtain chromatogram
and collect relevant
fractions.

Lower pH to ~ 3.0 and
then inject into SP
column

Elute protein
using PBS buffer

Add 20 μL thrombin
and leave in cold box
overnight with agitation
at 4oC.

Figure 9. Diagram illustrating protein purification by GST-tag affinity column and ion exchange
chromatography.
Proteins were further purified using ion exchange chromatography. The eluted protein’s
pH was lowered to a 3.0-4.0 range using acetic acid and it was subsequently filtered using 0.45
μm filter. Filtered solution was injected into SP column using a fast liquid chromatography
(FPLC) system. Proteins are bound to the column in buffer A (50 mM sodium acetate-acetic acid
buffer solution, pH 4.5) and they were eluted with buffer B (50 mM Tris-HCl, pH 8.0). The
FPLC system displayed a chromatogram with a sharp peak when the protein was eluted allowing
us to collect the relative fractions (Figure 9). Collected fractions were concentrated to 10 ml
using an Amicon brand concentrating apparatus with a 3-10 kDa molecular weight cutoff
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membrane. Concentrated solution was extensively dialyzed in 10 mM Tris-HCl buffer pH 7.4 to
perform further studies.
2.3.2

Nickel-sepharose affinity chromatography (6x-his-tag)
A 2 L expression cell pellet was re-suspended in 20 mL extraction buffer (20 mM Tris,

100 mM NaCl, 0.1% Triton X-100) or 30-50 mL lysis buffer (1% sacosine and 1 mM EDTA in
PBS, pH 7.4). Cell membranes were broken using sonication or French press. The resulting
solution was centrifuged for 40 minutes at 17,000 rpm and the extracted supernatant was filtered
with 0.45 μm pore size filter into a plastic tube. In order to improve protein purity, 1 M
imidazole was optionally added to the solution so that the final concentration was 20-50 mM.
Purification of His-tag proteins was completed using a Hitrap 20 mL or 5 mL sepharose
column and an ÄKTA prime FPLC instrument (Amersham Biosciences, Piscataway, NJ). Buffer
A (referred to as binding buffer) was comprised of 1 M K2HPO4, 1 M KH2PO4, 250 mM NaCl,
pH 7.4. Buffer B (referred to as elution buffer) was comprised of buffer A and 0.5 M imidazole.
The column was first rinsed with a 100 mM EDTA and 1 M NaCl solution in order to remove
any metals and undesirable impurities. It was then rinsed with ddH2O twice. Following the
cleaning step, the column was washed with 0.1 M NiSO4 in order to bind Ni2+ onto the column,
and it was then rinsed again with ddH2O in order to remove any unbound NiSO4. Filtered protein
was then injected into the column and further eluted out in 8 mL fractions. Collected fractions
were further purified by dialysis in 2 L of 10 mM Tris-HCl buffer pH 7.4 and using a dialysis
bag with a molecular weight cutoff of 3500 Da. The dialysis solution was changed every 3 hours
in order to remove imidazole (Figure 10).
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0.5 M imidazole

Filter supernatant and add
1 M imidazole to a final
concentration of 20 mM

Protein binds to Ni2+sepharose column (His-tag)

Figure 10. Diagram illustrating protein purification by 6x-his-tag affinity column step by step.
2.3.3

Hydrophobic interaction chromatography
A 2 L expression cell pellet was re-suspended in 30 mL homogenization buffer (2 mM

EGTA, 1 mM DTT, 1 mM PMSF in 50 mM Tris-HCl, pH 7.5) and cell membranes were broken
using French press. The resulting solution was subsequently heated at 80-85 oC in a water bath
for about 5 minutes and this solution was centrifuged for 40 minutes at 17,000 rpm. The
extracted supernatant was filtered with 0.45 μm pore size filter into a plastic tube and 1 M CaCl2
was added to a final concentration of 5 mM. The supernatant was then loaded onto a
phenylsepharose column that was previously equilibrated with wash 1 buffer (0.5 CaCl2 in 50
mM Tris-HCl, pH 7.5). The binding process was initially done at room temperature with a 1
mL/min binding flow and the sample was recycled overnight at 4 oC to ensure complete protein
binding to the column.
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Next day, the column was washed with 150 mL wash 1 followed by 150 mL wash 2
buffer (0.5 mM CaCl2, 500 mM NaCl in 50 mM Tris-HCl, pH7.5). Protein was eluted using
elution buffer (5 mM Na2EGTA in 50 mM Tris-HCl, pH 7.5) and the different fractions were
checked using UV-visible spectrophotometry. Relative fractions were collected, concentrated,
and dialyzed in 20 mM Tris-HCl buffer, pH 7.4 at 4 oC where the dialyzed buffer was exchanged
every 2-3 hrs (Figure 11). The final protein concentration was calculated using UV-visible
spectrophotometry, the protein’s extinction coefficient, and the measured absorption at 277 nm.
~ 85 oC

Supernatant
Cell pellet
Expression pellet was
dissolved in ~ 30 mL
homogenization buffer

Sonication or
French press

Dialysis in 20 mM
Tris-HCl buffer, pH 7.4

Cells were heated
in water bath for 5
min

Protein is eluded

CaCl2 to a concentration of 5 mM
was added

Protein bound to phenylsepharose column (HIC)

Figure 11. Diagram illustrating protein purification by hydrophobic interaction chromatography
step by step (phenylsepharose column).
2.3.4

Urea refolding
A 1 L expression cell pellet was re-suspended in 30-35 mL PBS buffer, 60 μL benzonase

nuclease, and 200 μL protease inhibitor. The resulting solution was subjected to French press
three times. The solution was centrifuged for 30 minutes at 17,000 rpm. The supernatant was
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discarded and the pellet was re-suspended in 20 mL 2% Titron X-100 in PBS solution and then
centrifuged for 20 minutes at 17,000 rpm. This procedure was repeated 3-4 times. The washed
pellet containing the protein was then transferred to two 50 mL plastic tubes and 25 mL of an 8
M urea (pH 7.3) and 5 mM EDTA (pH 11.3) solution was added to each tube and left at 4 oC
overnight on a magnetic stirring plate. Next day, the solution was centrifuged for 20 minutes at
17,000 rpm. The supernatant was collected which contained the solubilized protein that was
completely unfolded by the 8 M urea solution. It was then necessary to gradually reduce the urea
concentration in order to refold the protein. The 8 M urea sample was then diluted to 4 M urea
by adding 25 mL PBS buffer drop wise and by constantly stirring the sample at 4 oC for 2 hours.
The 4 M urea solution was then transferred to two dialysis bags in order to dialyze them in 2 M
urea for 4 hours. Dialysis bags were then transferred to a 2 L dialysis buffer (10 mM Tris-HCl
buffer pH 7.4 and 200 μL protease inhibitor) overnight. The dialysis buffer was subsequently
changed three times at three hour intervals in order to completely remove urea from solution.
The dialyzed solution was further purified using ion exchange chromatography. Figure 12
illustrates a simplified diagram describing the refolding method process.
Dissolve pellet
in PBS Buffer

French press
(3X)

Centrifuge
(30 min)

Slowly dilute to
4 M urea using
PBS (4 hrs)

Dissolve pellet in
8 M urea (O/N)

Wash pellet with
Titron X-100 (3X)

Dialysis in 2 M
urea (4 hrs)

Dialysis using
desired buffer

Inject to column

Pure Protein
Figure 12. Diagram illustrating protein purification using 8 M urea refolding method.
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2.4

SDS-PAGE electrophoresis
Samples to be analyzed were mixed with SDS-PAGE sample buffer (glycerol, 1 M Tris-

HCl buffer pH 6.8, SDS, bromophenol blue, and dH2O) and 5% β-mercaptoethanol to avoid S-S
bridges formation. Mixed and denatured samples were heated in a boiling water-bath for 10 min.
They were then loaded into a SDS casting gel containing a stacking gel on top (4%
polyacrylamide) and a resolving gel on bottom (15% or 8% polyacrylamide). A constant current
of ~ 110-120 V was applied and the samples were allowed to run until they migrated to the
bottom of the resolving gel. The gel was stained using Coomassie brilliant blue staining buffer
and 0.1% Coomassie blue R-250 methanol, acetic acid, dH2O 40:10:50 for 20 min and then
destained using destaining buffer solution (25% methanol, 7% acetic acid, and dH2O).
2.5

Protein concentration calculation
Protein concentration was determined using UV-visible spectrophotometry, the UV

absorbance at 280 nm or 277 nm (phenylalanine absorbance), the protein’s molar extinction
coefficient, and the Beer-Lambert Law,
A=εbc
where A is the measured absorbance at 280 nm or 277 nm, ε is the molar extinction coefficient, b
is the path length (1 cm), and c is the protein’s concentration. The absorbance at 280 nm
corresponds to tryptophan residues present in CD2 and its variants, while 277 nm corresponds to
tyrosine residues present in CaM.
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3.

THE GRAFTING APPROACH: PROTEIN PURIFICATION BY
AFFINITY AND ION EXCHANGE CHROMATOGRAPHY

3.1

Introduction
Most Ca2+-binding proteins contain multiple binding sites and they are therefore able to

bind Ca2+ cooperatively. The grafting approach is an excellent way to examine site-specific
Ca2+-binding properties. In this approach, a single EF-hand Ca2+-binding loop or predicted Ca2+binding sites are inserted into a scaffold protein [12, 15]. Chosen scaffold or host proteins must
adhere to a series of conformational and stability characteristics, and loop insertions into these
host proteins must follow certain criteria that are essential for successful and accurate metalbinding and conformational studies. Domain 1 of CD2 (CD2.D1) and enhanced green
fluorescence protein (EGFP) were the two chosen host proteins. Therefore, the usage of these
proteins in combination with a grafting approach will allow us to create an environment to
evaluate the intrinsic Ca2+-binding affinities of isolated binding sites and it will also allow us to
develop Ca2+ sensors by exploiting the intrinsic fluorescence properties of EGFP variants. In this
chapter discussion will focus on the expression and purification of engineered Ca2+-binding
proteins in which Ca2+-binding loops were inserted into CD2 and EGFP.
3.1.1

CD2.D1 as a host protein
CD2.D1 was chosen as a scaffold protein in order to create a model system and in that way

study Ca2+-binding by protein grafting. CD2 enhances T cell and NK cell activation by
interacting with CD48 or CD58 on the antigen-presenting cells and is one of the most
extensively studied non-Ca2+-binding cell adhesion proteins [18]. This protein has high structural
conformation stability and it is able to maintain its native structure when electrostatic changes
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have been made to its structure [12]. Therefore, CD2 was converted into a specific receptor for
Ca2+ by inserting Ca2+-binding loops into this host stable protein (Figure 13).

Figure 13. Model structure of CD2.D1 grafted with a putative Ca2+-binding EF loop.
STIM1 is a 685 amino acid long transmembrane protein that is located on plasma and
endoplasmic reticulum (ER) membranes [40]. The ER is essential in store-operated Ca2+ entry
and actually STIM1 can be considered as a Ca2+ sensor in the ER. The N-terminal region of
STIM1 facing the ER lumen contains a sterile α–motif (SAM) domain and an EF-hand motif [40,
41]. This EF-hand motif was inserted into CD2.D1 using the grafting approach in order to study
its metal-binding activity and dimerization. Also, a STIM1 mutant (STIM1.Mut) was designed
where two asparagines (D) in position 1 and 3 were mutated to alanines (A) in order to disrupt its
Ca2+-binding on the EF-loop. The model structure of CD2.STIM1 and CD2.STIM.mut with their
inserted sequences can be observed in Figure 14.
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STIM1
AVRNIHKLMDDDANGDVDVEESDEFLRED
STIM1.MUT A V R N I H K L M A D A A N G D V D V E E S D E F L R E D

Figure 14. Model structure of CD2.STIM1 and CD2.STIM1.Mut. EF-hand motifs were inserted
at position 52 connected by three Gly residues at both ends of the sequence.
The rubella virus is a member of the family Togaviridae (genus Rubivirus) and it causes a
disease commonly known as rubella [42-44]. This single-stranded enveloped virus has a genome
size of 9,762 nucleotides [42-44]. This genome consist of two long open reading frames (ORFs):
a 5’-proximal ORF encoding nonstructural proteins (NSP) and a 3’-proximal ORF encoding
structural proteins, one capsid protein, and two envelope glycoproteins [44, 45]. A Ca2+- binding
motif (12 residues long) located within the NS protease domain of the 5-proximal ORF of RUB
was predicted and grafted between Gly53 and Ala54 by PCR into CD2 [44]. The prediction was
done based on analysis of current data related to EF-hand proteins (Figure 15).
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Figure 15. Sequence alignment of EF-hand Ca2+-binding motif RUBCa (RV) and other EF-hand
motifs [44].
3.1.2

EGFP as a host protein
Green fluorescence protein (GFP) was first discovered and isolated by Shimomura and his

group in 1962 from a jellyfish, Aequorea victoria [46]. Since then, a series of GPF variants has
been created in order to enhance its biochemical characteristics. For example, enhanced GFP
(EGFP) is a GFP variant in which point mutations (F64L and S65T) were done in order to
enhance this protein’s folding efficiency [46, 47]. EGFP has been used as a host protein to
develop sensors by grafting Ca2+-binding motifs into sensitive locations of this protein by
choosing three different locations that were solvent accessible [48]. One of these sensors was
EGFP-172-EF-III in which the Ca2+-binding motif of CaM, loop III (DKDGNYISAAE) and the
EF-hand motif (EEEIREAFRVFDKDGNGYISAAELRHVMTNL) were grafted into EGFP [48].
This sensor was named Ca-G1 and its motifs were inserted in position 1 of EGFP that
corresponded to Glu172-Asp 173 within loop 9 [48] Figure 16.
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Ca-G1

EGFP(1-172)

E-III-F

EGFP(173-238)

Figure 16. Model structure of a EGFP-based Ca2+ sensor (Ca-G1) located in position 1.
3.2

Results and discussion
Engineered proteins were generated using a grafting approach where CD2.D1 and EGFP

were used as host proteins. The following section is divided into two parts. The first part
includes the expression and purification of CD2-WT and its variants while the second part
discusses the expression and purification of EGFP-WT and one of its variant.
3.2.1

Expression and purification of CD2-WT and variants by GST-fusion affinity and
ion exchange chromatography

3.2.1.1 CD2-WT expression
CD2-WT was expressed in E. coli BL21(DE3) at 37 oC as a fusion engineered protein
with a GST-tag in a pGEX-2T vector. The exponential expression growth curve for CD2-WT
clearly shows that the proteins reached an OD at 600 nm of approximately 2.0, 3-4 hrs after
induction (Figure 17A). The SDS gel confirmed that the protein was successfully expressed
since no protein was observed BI, but after IPTG induction (AI) protein expression increased
every hour, based on increased band thickness observed as a function of time (Figure 17B).
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Figure 17. (A) CD2-WT expression growth curve (Vector: pGEX-2T, LB media, BL21(DE3),
37 oC expression). (B) CD2-WT expression in E. coli.
3.2.1.2 CD2-WT purification
CD2-WT was purified using affinity (GST-tag) and ion exchange chromatography. The
purification SDS gel shows that most of the protein was in the soluble form (Sup) and that the
GST-tag located on the protein bound to the column (BAB), even though some protein was still
left in the waste (Wst) which is due to incomplete binding of the protein with the sepharose
column. The GST-tag was effectively cleaved using thrombin (BAC), and protein was eluted out
(Elu) using 1X PBS buffer (Figure 18A). The pH of the eluted protein was then reduced to ~ 3.0
using acetic acid for subsequent injection into an ÄKTA FPLC system containing an ionexchange column. The chromatogram showed that the relevant fractions were 18 to 21 (Figure
18B) and the SDS gel confirmed that these fraction showed >95% purity (Figure 18A). These
fractions were collected and subjected to dialysis in 10 mM Tris-HCl buffer, pH 7.4. The final
concentration was 1.8 mM in ~ 2 mL and the final yield was 23.4 mg/L.
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Figure 18. CD2-WT purification using affinity (GST-tag) and ion exchange chromatography.
(A) SDS gels: GST-tag affinity column chromatography (left) eluted fractions after ion exchange
chromatography (right) (B) ion exchange chromatogram (collected fractions 18-21).
3.2.1.3 CD2.STIM1 and CD2.STIM1.Mut expression
CD2.STIM1 and CD2.STIM.Mut were expressed in E. coli BL21(DE3) at 37 oC as a
fusion engineered protein with a GST-tag in a pGEX-2T vector. The exponential expression
growth curve for CD2.STIM1 clearly shows that the protein reached an OD at 600 nm of
approximately 1.4, 4-5 hrs after induction (Figure 19A). The SDS gel confirmed that the protein
was successfully expressed since no protein was observed BI but after IPTG induction (AI)
protein expression increased every hour, based on increased band thickness observed as a
function of time (Figure 19B). CD2.STIM1.Mut was expressed using the same conditions as
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those used for CD2.STIM1 and a similar expression trend was observed. SDS gel electrophoresis
confirmed the results.
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Figure 19. (A) CD2.STIM expression growth curve (Vector: pGEX-2T, LB media, BL21(DE3),
37 oC expression). (B) CD2.STIM expression in E. coli.
3.2.1.4 CD2.STIM1 and CD2.STIM1.Mut purification
These two engineered proteins were purified using affinity (GST-tag) and ion exchange
chromatography. The purification SDS gel shows that most of the protein was in the soluble
form (Sup) and that the GST-tag located on the protein bound to the column (BAB), even though
some protein was still left in the waste (Wst) due to incomplete binding of the protein with the
sepharose column. The GST-tag was effectively cleaved using thrombin (BAC), and protein was
eluted out (Elu) using 1X PBS buffer (Figure 20). The pH of the eluted protein was then reduced
to ~ 3.0 using acetic acid in order to be consequently injected into an ÄKTA FPLC system
containing an ion-exchange column. The chromatogram showed that the relevant fractions were
17 to 19. These fractions were collected and subjected to dialysis in 10 mM Tris-HCl buffer, pH
7.4. The final concentration for CD2.STIM1 was 1.1 mM in ~2 mL and the final yield was 14.4
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mg/L. A similar purification trend was observed for CD2.STIM1.Mut. Its final concentration
was 770.9 μM in ~2mL and the yield was 10.0 mg/L.
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Figure 20. CD2.STIM purification using affinity (GST-tag) and ion exchange chromatography.
(A) SDS gels: GST-tag affinity column chromatography and eluted fractions after ion exchange
chromatography (B) ion exchange chromatogram (collected fractions 17-19).
3.2.1.5 CD2.RUB.Ca expression
This protein was also expressed in E. coli BL21(DE3) at 37 oC as a fusion engineered
protein with a GST-tag in a pGEX-2T vector. The exponential expression growth curve for
CD2.RUB.Ca clearly shows that the protein reached an OD at 600 nm of approximately 1.8, 3-4

39
hrs after induction (Figure 21A). The SDS gel confirmed that the protein was successfully
expressed since no protein was observed BI but after IPTG induction (AI) the protein expression
increased every hour, based on increased band thickness observed as a function of time (Figure
21B).
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Figure 21. (A) Rub.Ca.EF expression growth curve (Vector: pGEX-2T, LB media, BL21(DE3),
37 oC expression). (B) RubCa.EF expression in E. coli.
3.2.2

Expression and purification of EGFP-WT and a variant using 6x-his-tag affinity
chromatography

3.2.2.1 EGFP-WT and EGFP-EF-172 expression and purification
Green fluorescence proteins are different form CD2 since they contain a chromophore
located at the center of a beta barrel structure. Chromophore formation is usually achieved at low
temperatures since these temperatures allow proper chromophore maturation. The chromophore
is responsible for this protein’s characteristic green color after its expression in E. coli and
further purification.
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EGFP-WT and EGFP-EF-172 proteins were expressed in E. coli BL21(DE3) as fusion
engineered proteins containing a 6x-his-tag in a pET28a vector. Cells were grown in LB media
containing 30 μg/mL kanamycin at an initial temperature of 37

o

C. Temperature was

subsequently reduced after IPTG induction (OD 0.6) to 30 oC overnight in order to increase
chromophore maturation. Both of these proteins were successfully expressed (Figure 22A and
Figure 23A) and were further purified using 6x-his-tag affinity chromatography (Figure 22B and
Figure 23B). Proteins were soluble after cells were disrupted using sound waves (sonication) and
the collected fractions were dialyzed in 10 mM Tris-HCl buffer, pH 7.4 in order to remove the
high imidazole concentration used to elute the protein. Fractions 12 and 13 for EGFP-WT and 13
and 14 for EGFP-EF-172 showed higher purity in the SDS gels (Figure 22B and Figure 23B) and
they were used for crystallization procedures. The final yields for the collected fractions were
73.6 mg/L and 10.2 mg/L for EGFP-WT and EGFP-EF-172 respectively.
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Figure 22. (A) EGFP-WT expression in E. coli (Vector: PET20a, LB media, BL21(DE3). (B)
EGFP-WT purification SDS gel using 6x-his-tag affinity chromatography.
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Figure 23. (A) EGFP-EF-III-172 expression in E. coli (Vector: PET20a, LB media, BL21(DE3).
(B) EGFP-EF-III-172 purification SDS gel using 6x-his-tag affinity chromatography.
3.2.2.2 EGFP-WT and EGFP-EF-172 crystallization
Proteins are able to form crystals by aligning themselves in repeating series of “unit cells”
forming a crystalline lattice, these crystalline lattices might be formed utilizing one of the most
common crystallization techniques, the hanging-drop method [49]. In this method, a drop
containing the purified protein, buffer, and precipitant is placed on a glass cover slip and it is
allowed to equilibrate with larger reservoirs containing similar buffers and precipitants in higher
concentrations and at different conditions.
To date, efforts to crystallize EGFP-WT in our laboratory have been unsuccessful.
Samples were prepared for both EGFP-WT and EGFP-EF-172 at room temperature using the
following precipitant solution: 10-15% PEG 4000 in 50 mM HEPES pH 8.0-8.5, 50 mM MgCl2,
10 mM 2-mercaptopethanol. Phase separations and oil shape profiles were observed in the
samples due either to low monovalent salt concentration or because the precipitant concentration
was too high (Figure 24). The observed results indicate that salt and PEG concentrations need to
be further optimized in order to obtain crystals for this protein.
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Figure 24. EGFP-WT crystallization. Phase separation and oil shape profiles were observed.
Similar conditions were used to grow crystals for EGFP-EF-172. Different PEG
concentrations (10-15%) and different pH (8.0-8.5) were also tested. The best conditions that
showed microcrystals were pH 8.0 and 8.4 and 10% and 13% PEG 4000 concentration (Figure
25). These conditions are still under investigation because these microcrystals appear to be
overlapping each other, forming crystal clusters. These clusters can be avoided by reducing
crystallization temperature in order to slow down the nucleation process.
EGFP-EF-172
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10% PEG 4000

pH 8.0
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Figure 25. EGFP-EF-172 crystallization. Microcrystal formation and crystal clusters profiles
were observed.
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3.3

Summary
A grafting approach was used to insert Ca2+-binding motifs into host proteins, CD2.D1 and

EGFP. These host proteins are easily expressed and purified, tolerate mutations, and their native
structures are not disrupted by strategic insertions of foreign sequences. Expression and
purification of these engineered proteins are initial and essential steps to perform future
physicochemical experiments (e.g. CD2, MS, NMR, titrations etc.). All engineered proteins were
expressed at 37 oC in E. coli BL21(DE3) LB media conditions using IPTG as a protein inducer.
CD2-WT, CD2.STIM1, and CD2.STIM1.Mut were purified using affinity (GST-tag) and ion
exchange chromatography. Conversely, EGFP-WT and EGFP-172-III-172 were purified using
6x-his-tag affinity chromatography and the collected fractions were used to grow crystals using
the hanging-drop method. Optimum salt and precipitant concentrations are still under
investigation since we were unable to obtain EGFP-WT crystals, and crystal clusters were
obtained for EGFP-EF-172. The purities of our engineered proteins were tested by SDS gel
electrophoresis and their yields and concentrations were between 10-23 mg/L and 366-1800 μM
in ~ 2 mL (Table 4).
Table 4. Concentrations and yields obtained for engineered proteins that were created using a
grafting approach
Protein

Yield Concentration
(mg/L) (μM) in 2 mL

CD2.WT

23.4

1800

CD2.STIM1

14.4

1100

CD2.STIM1.Mut

10.0

771

EGFP-WT

73.6

657

EGFP-EF-172

10.2

366
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4.

CALMODULIN: AN INTRACELLULAR PROTEIN PURIFIED BY
HYDROPHOBIC INTERACTION CHROMATOGRAPHY

4.1

Introduction
CaM is a small (~17 kDa) intracellular Ca2+-binding protein with four EF-hand motifs or

loops. This important and well-studied protein is able to regulate a series of important cellular
functions including secretion, metabolism, motility, signal transduction, and cell division and
growth [7]. Its primary structure is highly conserved in all cell types and it has been also
identified in prokaryotic systems where it changes its conformation upon Ca2+ addition [50].
CaM has four Ca2+-binding sites located in four different EF-loops since this protein has a
helix-loop-helix conformation (Figure 26A). These loops have different physiochemical
properties and amino acid residues that will influence their metal-binding affinities, especially its
interaction with Ca2+ (shown as dark grey spheres). For example, EF-loop I has two positively
changed residues at positions 2 and 11 while EF-loop IV contains an additional negatively
charged residue at position 11 (Figure 26B). Previous researchers in Dr. Yang’s laboratory have
performed studies in which EF-loops of CaM were inserted into CD2 domain 1 (CD2.D1) in
order to study their Ca2+-binding properties and affinities [50]. Figure 26C illustrates the model
structure of one of the grafted loops. CaM EF-loop III was grafted into CD2.D1 at position 52
connected by five Gly residues (3 at one end and 2 at the other end) in order to increase the
loop’s flexibility [50]. The insertion of the EF-loops did not change the host protein’s
conformation and it was concluded that EF-loop IV exhibited the weakest metal-binding affinity
while EF-loop I exhibited the strongest binding affinity [50].
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A

B

C

Figure 26. Three-dimensional structures of calmodulin using MOLSCRIPT.67. (A) Ribbon
diagram of CaM-calcium loaded form. (B) Local structures of loop I (top) containing two
positively charged residues and loop IV (bottom) containing an additional negatively charged
residue at loop position 11. (C) Model structure of domain 1 of CD2 (CaM-CD2-III-5G-52) with
EF-loop III grafted at position 52 (Trp-32 and Tyr-76 are highlighted in yellow) [50].
4.2

Results and discussion

4.2.1

CaM-WT expression using two growth media

CaM-WT was expressed in E. coli in a pET20b vector and using LB and

15

N labeled

minimal media. The cell strain used was BL21(DE3) and the IPTG concentration used to induce
protein expression was 150 mM in both media. The temperature for expression was different for
both media since

15

N labeled minimal media provides fewer nutrients for bacterial growth

compared to those provided by LB media. CaM-WT was successfully expressed at 37 oC in LB
media and bacteria were collected after 6 h induction (Figure 27). In contrast, this protein was
expressed at 25 oC in the minimal media and it was left in the shaker with agitation for an
overnight period (Figure 27). A clear band was therefore observed around the 14 kDa marker
band because the protein’s molecular weight is ~17 kDa.
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Figure 27. CaM-WT expression in two different growth media.
4.2.2

CaM-WT purification

CaM-WT was purified using hydrophobic chromatography and a phenyl-sepharose column.
This well studied protein exposes a hydrophobic surface upon Ca2+ binding and this hydrophobic
region allows for its purification since it can bind to the phenyl-sepharose column and it can be
eluted out by using chelating agents like EGTA. The purification SDS gels for two proteins
expressed in different media can be observed in Figure 28A (LB media) and Figure 28B
(minimal media). The SDS gels clearly show that most of the protein was in the soluble form
(Sup) after cells were disrupted with high pressure. It is also possible to observe that the protein
bound completely to the phenyl-sepharose column because no protein was left in the waste (Wst)
after intensive binding, and that the 8 mL eluted fractions contained high quantity of pure
protein. Relevant collected fractions were concentrated and dialyzed in 20 mM Tris-HCL buffer,
pH 7.4 and the dialyzed buffer was exchanged three times with time intervals between 2-3 h and
sometimes for an overnight period.
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Figure 28. CaM-WT purification using hydrophobic chromatography. (A) CaM-WT purification
and eluted fractions when protein was expressed in 1 L LB media. (B) CaM-WT purification and
eluted fractions when protein was purified in 2 L 15N labeled media.
Protein concentration was calculated using UV-visible spectroscopy, the extinction
coefficient (3030 M-1 cm-1), and the protein’s absorbance at 277 nm. A typical UV-visible
spectrum of CaM-WT can be observed in Figure 29 where it is also possible to observe that the
UV absorbance at 277 nm for tyrosine and phenylalanine at 257 nm. For the pure protein
expressed in LB media the A277

nm

was 0.2676, whereas for the pure protein expressed in

minimal media the A277 nm was 0.2074. The obtained absorbances at 277 nm were divided by the
extinction coefficient and multiplied by a dilution factor of 50. The calculated final
concentrations and yields of purified proteins were 4.4 mM and 74.8 mg/L (expressed in LB
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media) and 3.4 mM and 57.8 mg/L (expressed in

15

N labeled minimal media) in ~2 mL. It is

normal to obtain a higher amount of protein when the protein is expressed in LB media since the
nutrients provided by these media are higher than those provided by minimal media.

0.3

A 277 nm = 0.2676
0.25

A 277 nm = 0.2074

Abs.

0.2
0.15

CaM-W T (Minimal media)
0.1

CaM-W T (LB media)

0.05
0
240

250

260

270

280

290

300

310

320

330

Wavelength (nm)
Figure 29. CaM-WT UV-visible spectrum after protein was expressed in two growth media and
purified by hydrophobic chromatography. Protein concentrations were calculated using the
protein’s absorbance at 277 nm, its extinction coefficient, and Beer-Lambert Law.
4.2.3

Summary

CaM is an important intracellular Ca2+-binding protein with four EF-hand motifs that
undergoes a conformation change upon Ca2+ binding. CaM-WT was successfully expressed in E.
coli BL21(DE3) using two different media and temperatures. Expression in LB media was
performed at 37 oC whereas expression in 15N minimal media was performed at 37 oC overnight
because this media provided fewer nutrients to the cells and it required a longer incubation time.
CaM-WT was subsequently purified using hydrophobic interaction chromatography (phenyl-
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sepharose column) since this protein exposes a hydrophobic region when it binds to Ca2+
allowing its purification. The final yield for CaM-WT expressed in LB media was 74.8 mg/L
which was higher to that obtained when it was expressed in 15N minimal media (57.8 mg/L) due
to the media nutrients and the expression time and temperature. Future experiments were
performed with the purified protein. For example, CaM-WT expressed in

15

N minimal media

was used to perform NMR experiments to further study the effect that Ca2+ might have on this
protein’s molecular structure.
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5.

THE ROLE OF CALCIUM AND THE EXTRACELLULAR
CALCIUM-SENSING RECEPTOR

5.1

Introduction
The CaSR was cloned from bovine parathyroid tissue in 1993 by Dr. Brown and his

colleagues and since then researchers have been rigorously working in order to study this
important receptor [51-53]. The receptor is most highly expressed in organs like the parathyroid,
thyroid, and kidney and it is a key and crucial player in Ca2+ homeostasis maintenance since it
regulates the secretion of parathyroid hormone (PTH) [11, 52, 54, 55]. For example, primary
hyperparathyroidism (HPTH) involves an over activity of the parathyroid glands causing PTH
overproduction and elevated blood Ca2+ levels or a hypercalcemia condition [56].
Overproduction of PTH can lead to osteoporosis, kidney stones, peptic ulcers, and high blood
pressure [55]. Several diseases have been associated with mutations in the CaSR that are
intrinsically linked with Ca2+ homeostasis disorders. For instance, familial hypocalciuric
hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT) were associated with
inactivating mutations affecting one or both alleles [52].
The CaSR belongs to family C of G protein-coupled receptors and it recognizes Ca2+ as its
physiological ligand. It is comprised of a huge extracellular domain (ECD) of approximately 600
amino acid residues, a seven transmembrane domain (7 TMD), and an intracellular domain of
approximately 200 amino acids [11, 55, 57]. The CaSR is a dimer and its ECD is connected to
the 7 TMD by a cysteine-rich region. The crystal structure for this receptor has not yet been
elucidated yet but a model structure based on the X-ray structure of mGLuR1 has been
developed in order to illustrate the three important domains that comprise the CaSR (Figure 30).
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This model structure illustrates the dimeric form of the CaSR and it also shows the location of
the five predicted Ca2+-binding sites.

Figure 30. Molecular modeling of the dimeric extra cellular domain (ECD) of the Ca2+-sensing
receptor (CaSR) based on the ECD X-ray structure of mGluR1 [58].
5.2
5.2.1

Two approaches to study the metal-binding properties of the CaSR
Grafting approach
Five putative Ca2+-binding sites were predicted and two of them (site 3 and 5) were

grafted into CD2.D1 using a well-studied grafting approach developed in Dr. Yang’s lab.
Therefore, we have converted CD2 into a specific receptor for Ca2+ by inserting a Ca2+-binding
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site into CD2.D1 between glycine 53 (G53) and serine 52 (S52) (Figure 31). The location of the
Ca2+-binding sites on the ECD (Figure 32A) and the proposed model structures for all five sites
is illustrated in (Figure 32B) where sites 3 and 5 are circled in red. Lobe 1 of the ECD of the
CaSR contains sites 4 and 5, whereas lobe 2 contains sites 1, 2, and 3. Site 1 is expected to be
important in Ca2+-induced conformational changes since this site is located at a hinge region
connecting both lobes. Additionally, the physiochemical properties of CD2.CaSR site 3 and 5
and their mutants are summarized in Table 5 where it is possible to observe the individual
grafted sequences, isoelectric points (pI), and molecular weights (kDa) for sites 3 and 5 and their
mutants. Glycine linkers were added at each insertion site in order to study the loop’s flexibility
upon linker addition.
Table 5. Grafted sequences, isoelectic points (pI), and molecular weights for CD2.CaSR site 3,
site 5, and mutants

Protein

Grafted Sequence

pI

MW (kDa
(kDa))

CD2.CaSR5

GHEESGDRFSNSSTAFRPLCTGDENI

5.97

14.1

CD2.CaSR5.Mut1

GHAASGDRFSNSSTAFRPLCTGDENI

7.38

14.0

CD2.CaSR5.Mut2

GHEESGDRFSNSSTAFRPLCTGAANI

7.38

14.0

CD2.CasR5 linker

KSGGGHEESGDRFSNSSTAFRPLCTGDENIGGGSA

7.38

12.9

CD2.CaSR3

GIEKFREEAEERDIG

5.59

13.0

CD2.CaSR3.Mut1

GIAKFREEAEERDIG

7.19

12.9

CD2.CaSR3.Mut2

GIEKFRAAAEERDIG

7.19

12.9

CD2.CaSR3.Mut3

GIEKFREEAAARDIG

7.19

12.9

CD2.CaSR3 linker

KSGIEKFREEAEERDIGA

5.59

13.3

53

Figure 31. Model structure of CD2.D1 grafted with a putative Ca2+-binding site inserted
between serine 52 and glycine 53.

A

B

Site 1

Site 2

Site 3

Site 4

Site 5

Figure 32. (A) ECD of the CaSR illustrating possible locations of five potential Ca2+-binding
sites in lobes 1 and 2 and the predicted residues at each site. (B) Proposed structures for potential
Ca2+-binding sites in the ECD of the CaSR. Site 3 and site 5 shown in red.
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5.2.2

Subdomain approach
The strategy of the subdomain approach is to chop intact CaSR into three subdomains

containing the identified Ca2+-binding sites. The objective of this strategy is to understand the
cooperativity of coupled Ca2+-binding sites and to study Ca2+-induced conformational changes
[10]. Three constructs were designed encompassing subdomains that include different numbers
of predicted Ca2+-binding sites of the CaSR. Subdomain 1 contains CaSR sites 1, 2 and 3,
subdomain 2 contains sites 2 and 3 in lobe 2, and subdomain 3 contains sites 4 and 5 in lobe 1
(Figure 33).
Site1: S147, S170, D190, Y218, E297

Subdomain 2 (sites2+3)324

185

Site2: D215, L242, S244, D248, Q253
Site3: E224, E228, E229, E231, E232
Site4: E350, E353, E354, N386, S388
Site5: E378, E379, T396, D398, E399

Lobe 1

132

Lobe 2

Lobe 2

Lobe 1

300

340

Subdomain 1 (sites1+2+3)

445

Subdomain 3 (sites4+5)

site4
site5
site3

site1
site3

site2

site2

Subdomain 1

Subdomain 2

Subdomain 3

kDa)
(21 kDa)

kDa)
(16 kDa)

kDa)
(12 kDa)

Figure 33. Diagram illustrating the subdomain approach: ECD of the CaSR is chopped into 3
subdomains. Subdomain 1 contains sites 1, 2, and 3. Subdomain contains sites 2 and 3.
subdomain 3 contains sites 4 and 5.
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The physiochemical properties of the three subdomains including the extinction
coefficient, the isoelectric point, the number of cysteine residues, and the molecular weight
(kDa) can be observed in Table 6.
Table 6. Physiochemical properties of three subdomains located in the ECD of the CaSR

Protein

Amino acid from
CaSR

Extinction
Coefficient (M-1 cm-1)

Cys No.

pI

MW
(kDa)
kDa)

Subdomain 1

S132-A300

36,130

1

4.59

22.9

Subdomain 2

R185-A324

34,850

1

4.62

20.3

Subdomain 3

A323-G494

27,550

5

5.05

23.8

5.3
5.3.1

Results and discussion
CD2.CaSR site 3 and 5 expression and purification using GST-fusion technology

5.3.1.1 CD2.CaSR site 3 and 5 expression in LB media
Site 3 and site 5 from the CaSR were inserted into CD2.D1 and they were successfully
expressed as fusion proteins with a GST-tag in a pGEX-2T vector transformed into E. coli cell
strain BL21(DE3) and IPTG was used as the inducer. The exponential expression growth curve
clearly shows that the proteins reached an OD at 600 nm of approximately 2.0 300-350 min (3-4
hrs) after induction (Figure 34A). SDS gels confirmed that the proteins were successfully
expressed since protein expression was not observed before induction (BI) but after IPTG
induction (AI) protein’s expression increased every hour as the bands were getting thicker and
thicker as the hours were elapsing (Figure 34B).
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Figure 34. (A) CD2.CaSR site 3 and site 5 expression growth curve (Vector: pGEX-2T, LB
media, cell strain: BL21(DE3), 37 oC expression). (B) SDS gels showing CD2.CaSR site 3 (left)
and site 5 (right) expression.
These two proteins were purified using affinity (GST-tag) and ion-exchange
chromatography. Engineered proteins are frequently subject to solubility problems but in this
case the amount of soluble protein (in the Sup form) that was obtained after cell disruption was
enough to perform future purification steps. The supernatant was poured into sepharose-columns
where the GST was initially bound to the column (BAB), subsequently cleaved using thrombin
(BAC), and eluted out (Elu) using 1X PBS buffer (Figure 35). The pH of the eluted protein was
then reduced to ~3.0 using acetic acid for subsequent injection into an FPLC system containing
an ion-exchange column. The chromatogram revealed relevant fractions that were collected and
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subjected to dialysis in 10 mM Tris buffer pH 7.4. Both proteins showed a clear and pure band
around ~14 kDa (site 5) and ~13 kDa (site 3) on the SDS gels Figure 35A and Figure 35B
respectively.

B

A kDa

kDa
―64

64―

24―

―24

14―

―14

C/P Sup BAB BAC Elu

C/P Sup BAB BAC Elu

Figure 35. CaSR site 3 and site 5 purification using affinity (GST-tag) and ion exchange
chromatography. SDS gels and ion exchange chromatograms for (A) CaSR site 5 and (B) CaSR
site 3.
5.3.1.2 CD2.CaSR site 3 and 5 expression in minimal media
Additionally, efforts were made to express and purify CD2.CaSR site 3 and 5 in

15

N

labeled minimal media for NMR analysis to obtain structural information of the predicted sites.
Both proteins were successfully expressed and purified using similar approaches as those
employed for regular LB expression. The expression level was reduced to that observed in LB
media expression because minimal media provided fewer nutrients for bacterial growth (Figure
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36A). Since the expression level was reduced, the final eluted protein amount was also reduced
when it was purified by affinity and ion exchange chromatography as confirmed by the SDS gels
of both proteins (Figure 36B).
A
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Figure 36. (A) Expression of CaSR site 3 and site 5 in 15N labeled minimal media (BL21(DE3),
37 oC expression). (B) Purification of CaSR site 3 (left) and site 5 (right) by GST-tag affinity
column.
5.3.2

Subdomain 1 expression and purification optimization

5.3.2.1 Expression and cell disruption using different vectors
Subdomain 1 expression was performed using fusion technology in order to compare the
protein’s expression and solubility after cell disruption. Three different vectors were evaluated:
pGEX-2T (GST-tag), pET32a (6x-his and thx-tag), and pRSETa (6x-his tag). The expression
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conditions were the same (E. coli BL21(DE3) at 37 oC) for all three vectors. Subdomain 1
showed a higher expression level when it was expressed using pGEX-2T and pET32a, but it was
also expressed to a lower extent in pRSETa (Figure 37A). Protein solubility was investigated by
breaking the cell using sonication. The protein formed inclusion bodies in the C/P in all three
cases as observed in Figure 37B. Most of the protein was therefore identified within the C/P and
not in the Sup form. The only vector that showed a significant amount of protein in the soluble
form was pET32a but the thx-tag could not be removed from the target protein.
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Figure 37. Subdomain 1 expression and cell disruption using three vectors. (A) Protein was
expressed at 37 oC in E. coli BL21(DE3) using pGEX-2T (GST-tag), pET32a (6x-his-thx-tag),
and pRSETa (6x-his-tag). (B) Cell disruption in order to investigate subdomain 1 solubility.
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5.3.2.2 Subdomain 1 expression optimization using pRSETa
Subdomain 1 was cloned in pRSETa vector between BamHI and EcoRI restriction sites
by Dr. Yun Huang. This vector contained a 6x-his-tag region that was used for further
purification. The 6x-his-tag not only facilitated the subdomain 1 purification, but the protein’s
expression was further optimized by utilizing different cell strains and temperatures.
Protein was transformed and expressed in four E. coli cell strains: BL21(DE3),
BL21(DE3)pLysS, tuner(DE3)pLacI, and rosetta(DE3)pLysS. These cells strains have different
properties and these properties had diverse effects in subdomain 1 expression and further
purification. All the chosen cell strains were T7-based expression systems that control proteases
at the cellular level. The pLysS plasmid provided a reduction of basal expression and therefore a
tight expression was expected. Rosetta cell strain offered a universal translation because it
provided tRNAs that rarely occur in E. coli. Additionally, both rosetta and tuner had deletions in
the lacY gene (lac permease) that allowed these cell strains to control expression levels upon
different IPTG concentrations.
Cells were induced when the OD reached ~0.6 with IPTG. The expression growth curves
show that the maximum OD or the maximum amount of bacteria that grew in the media fell
between 1.0-1.2 when the protein was expressed at 37 oC (Figure 38A), and that the OD was
higher between 1.2-1.8 when the protein was expressed at 30 oC overnight (Figure 38B). A
higher OD reading was observed for BL21(DE3) at both temperatures and rosetta(DE3)pLysS
showed the lowest OD reading at 30 oC. These graphs illustrate typical exponential bacterial cell
growth curves where bacteria exhibit a slow initial growth rate (~0 to 200 min) which increases
to a faster exponential growth rate (~200 to 400 min) until it reaches a stationary phase (~400 to
1000 min).
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Figure 38. Subdomain 1 expression growth curve using four cell strains and two temperatures.
(A) Protein expressed at 37 oC (B) Protein expressed at 30 oC overnight.
Additionally, the SDS gel shows that subdomain 1 was successfully expressed in all cell
strains at 37 oC and that the expression band was thicker when this protein was expressed using
rosetta(DE3)pLysS (Figure 39A).

Additionally, this protein was not expressed when

BL21(DE3) was used as the cell strain at 30 oC overnight even though its OD was the highest
among the other three cell strains (Figure 38B and Figure 39B) . This means that having a high
OD does not guarantee that the protein is being expressed correctly. In contrast, subdomain 1
was successfully expressed in the other three cell strains at 30 oC expression. The best cell
strains that expressed subdomain 1 were rosetta(DE)pLysS and tuner(DE3)pLacI at 30 oC
overnight (Figure 39B). The intensity change was calculated using ImageJ software (National
Institutes of Health, Bethesda, MD). The cell strain that showed the higher intensity change BI
and AI was rosetta(DE3)pLysS at both temperatures and the intensity change was more evident
when cells were expressed at low temperatures (Figure 39C). This means that lowering the
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temperature increased protein expression since proteins had more time to properly fold and the
bacteria was able to grow longer since expression at lower temperatures is usually performed
overnight.
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Figure 39. Subdomain 1 expression optimization using four cell strains and two temperatures.
(A) Protein was expressed at 37 oC (B) Protein expressed at 30 oC overnight. (C) Intensity
change AI/BI for subdomain 1 expression using different cell strains and temperatures.
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5.3.2.3 Subdomain 1 purification using affinity chromatography
Expressed proteins were further purified using affinity chromatography and a Ni2+sepharose column using the 6x-his rich region provided by the pRSETa vector. Cells were
disrupted using French press and it was found that a larger proportion of insoluble aggregates
was formed when the protein was expressed at 37 oC. The cell strain that formed the highest
amount of insoluble aggregates present in the C/P was BL21(DE3) and as a consequence this
strain presented the lowest yield (1.2 mg/L) and concentration (26 μM) among all other cell
strains (Table 7 and (Figure 40A). In comparison, BL21(DE3)pLysS and rosetta(DE3)pLysS
exhibited better yields (4.0 mg/L and 6.2 mg/L) and concentrations (88 μM and 135 μM
respectively) and, although the protein still formed inclusion bodies, a significant amount of
protein was soluble and could be further injected into the FPLC system and eluted out with high
(50 mM) imidazole concentration (Table 7, Figure 40B, and Figure 40C). Relevant eluted
fractions from the FPLC system were collected, concentrated down, and dialyzed in 10 mM TrisHCl buffer, pH 7.4 in order to remove imidazole from the protein.
Table 7. Subdomain 1 concentrations and yields after 6x-his-tag affinity chromatography
Cell strain

Concentration (μM)* Yield (mg/L) Concentration (μM)*
(37 oC)
(37 oC)
(30 oC)

Yield (mg/L)
(30 oC)

BL21(DE3)

26

1.2

n/a

n/a

BL21(DE3)pLysS

88

4.0

306

14.0

Tuner(DE3)pLacI

n/a

n/a

503

23.0

Rosetta(DE3)pLysS

135

6.2

788

36.1

* Protein volume ~ 2 mL
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Figure 40. Subdomain 1 purification using 6x-his-tag affinity chromatography. Protein was
expressed in LB media at 37 oC using three different cell strains: (A) BL21(DE3) (B)
BL21(DE3)pLysS and (C) Rosetta(DE3)pLysS. Red boxes: most of the protein formed
inclusion bodies or insoluble aggregates in the cell pellet and a low amount of soluble protein
was present in the supernatant.
Subdomain 1 was more soluble when it was expressed at 30 oC and these results can be
corroborated by the purification SDS gels when they were expressed in three different cell
strains (Figure 41). Inclusion bodies were still present in C/P but to a lesser extent compared to
expressed protein at 37 oC. We were able to obtain higher yields and concentrations when the
protein was expressed at a lower temperature (Table 7 and Figure 42). Lower temperature
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expression improved the protein’s solubility because bacteria grew at a slower rate and the
protein had more time to fold properly (Figure 41A-C). The cell strain that had the highest yield
and concentration (in ~2mL) was rosetta(DE3)pLysS (36.1 mg/L and 788 μM), followed by
tuner(DE3)pLacI (23.0 mg/L and 503 μM), and BL21(DE3)pLysS (14.0 mg/L and 306 μM)
(Table 7).
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Figure 41. Subdomain 1 purification using 6x-his-tag affinity chromatography. Protein was
expressed in LB media at 30 oC overnight using three different cell strains. (A)
BL21(DE3)pLysS, (B) Tuner(DE3)pLacI, and (C) Rosetta(DE3)pLysS. Red boxes: protein
formed a lower amount of insoluble aggregates in the cell pellet compared to protein expression
at 37 oC.
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Figure 42. Subdomain 1 final yields were affected by expression temperatures and cell strains.
Soluble and insoluble fractions in the supernatant and in the cell pellet were compared
using purification SDS gels and the respective fractions were calculated using ImageJ software
(Figure 43). It was observed that soluble fractions were only 16% and 41% for
BL21(DE3)pLysS and rosetta(DE3)pLysS respectively when the protein was expressed at 37 oC
(Figure 43A). However, when the protein was expressed at 30 oC, soluble fractions for
BL21(DE3)pLysS and rosetta(DE3)pLysS remarkably increased to 57% and 83% (Figure 43B).
The cell strains that produced the higher percentages of insoluble aggregates were BL21(DE3)
expressed at 37 oC with 92% in the insoluble form and tuner(DE3)pLacI at 30 oC with 85%.
Tuner(DE3)pLacI was insoluble to a large extent due to overexpression of the protein resulting
in production of inclusion bodies. Since this cell strain is IPTG dependent, protein expression
was not regulated. On the other hand, better results were obtained with cell strains that had a
pLysS plasmid because the cell strains that contained this plasmid allowed a tight and selective

67
expression. The results shown in Figure 43 confirmed that lower expression temperature
enhanced protein solubility.
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Figure 43. Expression temperature and cell strains affected subdomain 1 solubility. (A)
Insoluble and soluble percentages when protein was expressed at 37 oC. (B) Insoluble and
soluble percentages when protein was expressed at 30 oC overnight. Percentages were calculated
using ImageJ software.
Protein concentration was calculated using the extinction coefficient of subdomain 1
(36,130 M-1 cm-1) and its UV-vis absorbance at 280 nm.
5.3.3

Subdomain 2 expression and purification
The best expression and purification conditions used for subdomain 1 were used to

express subdomain 2. This protein was therefore successfully expressed in E. coli
rosetta(DE3)pLysS at a temperature of 30 oC overnight (Figure 44). Subdomain 2 molecular
weight is ~20 kDa and a clear band can be observed close to the 24 kDa mark. Expressed protein
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was further purified using 6x-his-tag affinity chromatography and the final yield was 7 mg/L and
a concentration of 363 μM in ~2 mL (Figure 44).
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Figure 44. Subdomain 2 expression and purification using 6x-his-tag affinity chromatography.
(LB media, rosetta(DE3)pLysS, 30 oC overnight expression).
5.3.4

Subdomain 1 and 2 expression in 15N labeled minimal media
Additional efforts were made to express and purify subdomain 1 and 2 in

15

N labeled

minimal media. These two engineered proteins were expressed in E. coli BL21(DE3)pLysS,
rosetta(DE3)pLysS, and tuner(DE3)pLacI. The best cell strain that expressed these proteins with
the least amount of insoluble aggregates in C/P was tuner(DE3)pLacI for both of these proteins
(see red boxes in Figure 45A). The SDS gel clearly shows that the proteins were expressed and
that even though a large amount of protein was present in the C/P a significant amount of protein
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was in the Sup or soluble form. Additionally, these proteins were purified using 6x-his-tag
affinity chromatography and the SDS purification gel for subdomain 1 can be observed in Figure
45B.
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Figure 45. (A) Subdomain 1 and subdomain 2 expression using 15N labeled minimal media
(tuner(DE3)pLacI) and cell disruption using French press. (B) Subdomain 1 purification using
6x-his-tag affinity chromatography.
5.3.5

Subdomain 3 expression optimization
Four cell strains at different temperatures were tested: rosetta(DE3)pLysS at 30 oC

overnight, BL21(DE3) at 37 oC, BL21(DE3)pLysS at 30 oC overnight, and tuner(DE3)pLacI at
37 oC in order to express this protein. The optimum expression conditions used for subdomain 1
and 2 did not express subdomain 3. One possible reason is that this protein has four more
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cysteines and these residues could cause folding problems. This protein was only successfully
expressed in tuner(DE3)pLacI at an expression temperature of 37 oC and 1 mL/L IPTG was used
for induction (Figure 46). This protein was not expressed using any other of the tested cells
strains (Figure 46).
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Figure 46. Subdomain 3 expression optimization using four cell strains and two temperatures.
Protein was expressed at 37 oC in LB media.
5.3.6

Subdomain 3 purification optimization
Subdomain 3 was purified at first using His-tag affinity chromatography but the collected

fractions contained a low amount of pure protein because most of the protein was in the pellet
forming insoluble aggregates after the cell was disrupted using French press (Figure 47A). The
pellet containing the protein was subsequently solubilized and completely unfolded using 8 M
urea then refolded by gradually removing urea. Therefore, the 8 M urea solution was diluted to 4
M urea, dialyzed in 2 M urea, and then dialyzed in 10 mM Tris-HCl buffer, pH 7.4. The protein
was then identified in the Sup after it was treated with urea (Figure 47A). The Sup containing the
soluble and refolded protein was further purified using 6x-his-tag affinity chromatography
(Figure 47B). Relevant fractions from the FPLC were collected (fractions 9 to 19), dialyzed in
10 mM Tris-HCL buffer pH 7.4, and concentrated down to ~2 mL. The calculated final
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concentration using UV-visible spectroscopy was 300 μM in a 2 mL volume and the final yield
was 7 mg/L.
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Figure 47. Subdomain 3 purification. SDS gels, (A) Subdomain 3 purification from insoluble
aggregates. Pellet (P) and supernatant (sup) before and after refolding. Red box: protein is now
in soluble supernatant form. (B) Subdomain 3 collected fractions after affinity chromatography.
5.3.7

Structural and conformational analyses for subdomains of the CaSR
Secondary and tertiary structures of the three subdomains and their conformational

changes upon Ca2+ addition were investigated by Dr. Yun Huang using CD spectroscopy and
intrinsic tryptophan (Trp) fluorescence (details can be observed in her thesis dissertation) [38].
The three subdomains exhibited typical helical secondary structure with negative signals at 208
nm and 222 nm (Figure 48A) as it was predicted by their model structures (Figure 48B). The
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model structures of subdomain 1 and 2 clearly show a high globular helical content, however a
lower number of helices was observed in subdomain 3 and that explains why subdomain 3
exhibited a slightly different CD spectrum compared to the other subdomains (Figure 48B).
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Figure 48. Structural analysis of subdomains using CD spectroscopy (A) Subdomains exhibited
typical helical secondary structures. (B) Predicted model structures for each subdomain
exhibiting high helical content.
Subdomains’ conformational changes upon Ca2+ addition were investigated using CD
spectroscopy and Trp fluorescence. CD spectra changes were observed for subdomain 1 and 3
after addition of saturating amounts of Ca2+ indicating that the secondary structure for these two
subdomains is changing to a more helical form. Additional changes were observed for Trp
fluorescence spectra indicating a change in the tertiary structure; this change was particularly
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evident for subdomain 1 since an increase in the Trp fluorescence intensity was observed (Figure
49).
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Figure 49. Conformational changes of the subdomains upon Ca2+ binding. (A) Far UV-CD
spectra. (B) Trp fluorescence spectra [10].
5.3.8

Subdomain 1 metal-binding process
An additional metal-binding study that includes a Tb3+-luminescence resonance energy

transfer was performed by Dr. Yun Huang (details can be observed in her thesis dissertation)
[38]. This metal-binding process confirmed that subdomain 1 exhibited a biphasic binding
process as can be observed in Tb3+-titration curve (Figure 50). This curve clearly shows that at
least 2 metal-binding processes or components are occurring in subdomain 1. The first
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component was attributed to site 1 and the second component corresponds to site 3 as it was
concluded by Dr. Yun Huang [10].
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Figure 50. Tb titration curve for subdomain 1. Subdomain 1 exhibited at least two metalbinding processes [38].
5.3.9

Extracellular domain (ECD) of the CaSR
The ECD of the CaSR is a huge domain with a molecular weight of ~73 kDa and this

protein has not been expressed before in E. coli. This protein’s expression and purification has
been challenging due to its size, its extracellular environment, and the presence of ~20 cysteine
residues in its original sequence and a rich cysteine region that connects the ECD with the
7TMD of the CaSR [51] (Figure 51). We have predicted five Ca2+-binding sites located on the
ECD and we have divided the ECD into three subdomains. The expression and purification of
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the ECD is essential in order to further investigate how the three subdomains and their respective
Ca2+-binding sites interact with each other.

Figure 51. ECD of the CaSR contains 20 cysteine residues and a cysteine-rich region of 9
cysteine residues (pink box) that connects the ECD with a 7 TMD [51].
The following data show recent efforts made in order to express and purify this protein. It
is important to mention that these are the best conditions that have been achieved to date, but
further optimization procedures are being evaluated. The most recent purified protein using the
best conditions up to this point showed low stability and degradation.
5.3.9.1 ECD expression optimization
ECD was cloned in a pRSETa vector containing a 6x-his-tag region in order to be purified
using affinity chromatography in the same manner as its subdomains. Since the molecular weight
of this protein is close to 73 kDa it was necessary to use 8% SDS gels in order to observe its
purity and molecular weight band using gel electrophoresis.
This protein was first expressed in E. coli rosetta-gami(DE3)pLysS at 37 oC. Cells were
growing at a very slow rate but they were still collected the same day after induction (3 h AI)
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(Figure 52). Additional efforts were made to express this protein at 3 different temperatures 25
o

C, 30 oC, and 37 oC overnight in order to determine if the temperature and expression time

could affect the ECD expression. Temperature and expression time indeed affected this protein’s
expression because ECD was not expressed at low temperatures (25 oC and 30 oC) but it was
expressed at 37 oC both during a single day and overnight expression (Figure 52). The SDS gel
clearly shows that the protein was better expressed at 37 oC overnight. The same conditions were
utilized to express the ECD in tuner(DE3)pLacI at 37 oC overnight but this cell strain expressed
other proteins besides ECD. OrigamiB(DE3)pLysS at 30 oC overnight was also tested and
actually a more pronounced expression band was observed in origamiB(DE3)pLysS when
compared with the other two cell strains (Figure 53A). Additionally, origamiB(DE3)pLysS
obtained the higher intensity change AI/BI followed by rosetta-gami(DE3)pLysS and
tuner(DE3)pLacI (Figure 53B). Therefore, a higher expression level was observed with origamiB(DE3)pLysS and rosetta-gami(DE3)pLysS because these two cell strains contain mutations in
the thioredoxin and glutathione reductase facilitating disulfide bond formation in the cytoplasm.
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Figure 52. ECD of the CaSR expression at three temperatures (Vector: pRSETa, LB media).
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Figure 53. ECD of the CaSR expression. (A) Expression using different cell strains:
tuner(DE3)pLacI, rosetta-gami(DE3)pLysS, and origamiB(DE3)pLysS at 37 oC and 30 oC
overnight (Vector: pRSETa, LB media). (B) Intensity change AI/BI for ECD expression using
different cell strains.
5.3.9.2 ECD purification optimization
Expressed protein was further purified using 6x-his-tag affinity chromatography. A few
changes were made to the protocol used for the subdomains purification because when the same
protocol was used for ECD purification a significant amount of protein degraded. Two major
changes were therefore made to the usual 6x-his-tag affinity chromatography purification. The
first change was dissolving the expression pellet in lysis buffer with two tablets of protease
inhibitor. This step was done in order to prevent degradation of the protein by proteases. The
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second change was that the initial imidazole concentration of the solution before it was injected
into the FPLC was increased from 20 mM to 50 mM. This step was done in order to increase the
binding competition between imidazole and protein so that the purity could be increased.
Protein was purified using affinity chromatography and the best results were obtained
when the protein was expressed in rosetta-gami(DE3)pLysS at 37 oC overnight (Figure 54A).
However, degradation was observed and the presence of insoluble aggregates in the C/P was also
evident in all three cases (Figure 54A-C). Collected fractions from the His-tag column were
dialyzed in 10 mM Tris-HCl buffer, pH 7.4 and consequently concentrated down to ~2 mL. The
final concentration was calculated using UV-vis spectroscopy, protein’s absorbance at 280 nm,
and its extinction coefficient which is 110,300 M-1 cm-1. The final yields were 12.7 mg/L, 3.9
mg/L, and 6.7 mg/L for rosetta-gami(DE3)pLysS, tuner(DE3)pLacI, and origamiB(DE3)pLysS
respectively (Table 8). Optimum purification conditions for this protein are still under
investigation but the best conditions to date were observed with rosetta-gami and origamiB since
they facilitate disulfide-bond formation in the cytoplasm.
Table 8. ECD final yields when protein was expressed in different cell strains

Cell strain

Yield (mg/L)

Rosetta(DE3)pLysS

12.7

Tuner(DE3)pLacI

3.9

Origami-B(DE3)pLysS

6.7
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Figure 54. ECD of the CaSR purification using 6x-his-tag affinity chromatography. (A) Protein
was expressed in E. coli rosetta-gami(DE3)pLysS, (B) tuner(DE3)pLacI, and (C)
origamiB(DE3)pLysS.
5.4

Summary
Five predicted Ca2+-binding sites of the CaSR (sites 3 and 5) were grafted into CD2 and

two out of those five were expressed in E. coli BL21(DE3) at 37 oC. Since these sites were
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previously cloned in a pGEX-2T vector containing a GST-tag, further purification was
performed using affinity and ion-exchange chromatography. The predicted Ca2+-binding sites
were subjected to a series of experiments that confirmed that they are indeed Ca2+-binding sites
of the CaSR.
The ECD of the CaSR was cleaved into three subdomains that contained the predicted
Ca2+-binding sites. Subdomain 1 was first expressed in E. coli BL21(DE3) using three different
vectors: pGEX-2T, pET32a, and pRSETa. This protein formed insoluble aggregates in all three
cases and for that reason additional efforts were made to optimize subdomain 1 expression and
purification utilizing pRSETa vector. This protein was therefore expressed in four different cell
strains and two temperatures. Expressed proteins were then purified using 6x-his-tag affinity
chromatography in order to determine whether the protein formed insoluble aggregates after cell
disruption. The best results were obtained when subdomain 1 was expressed in
rosetta(DE3)pLyS at 30 oC overnight. Therefore, lower temperatures slowed down the protein
expression allowing proper protein folding and increasing its solubility.
The same expression and purification conditions were used to successfully express and
purify subdomain 2. Therefore, subdomain 2 was also expressed in rosetta(DE3)pLysS at 30 oC
overnight and purified using affinity chromatography.
On the other hand, subdomain 3 was expressed using a different cell strain
tuner(DE3)pLacI since it was not expressed in rosetta(DE3)pLysS, BL21(DE3), or
BL21(DE3)pLysS. This protein was purified from insoluble aggregates by refolding the protein
followed by affinity chromatography.
All three subdomains were successfully purified with concentrations between 300 to 800
μM in a volume of ~ 2 mL and yields between 7 to 36 mg/L (Table 7). Additional efforts have
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been recently made to express and purify the ECD of the CaSR. The best results show that this
protein was successfully expressed in E. coli rosetta-gami(DE3)pLysS at 37 oC overnight and
origamiB(DE3)pLysS at 30 oC overnight. This protein was purified using affinity 6x-his-tag
chromatography. Additional efforts have been made in order to optimize the expression and
purification of the ECD of the CaSR since this protein has shown low stability and
concentrations due to its size and presence of a high number of cysteine residues.
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6.

THE DESIGN APPROACH: PROTEIN PURIFICATION FROM
INCLUSION BODIES

6.1

Introduction
The purpose of the design approach is to use a computer algorithm to generate potential

Ca2+-binding sites and then incorporate those sites into a chosen host protein (CD2) using sitedirected mutagenesis [15]. The advantage of this approach is that it will allow us to understand
the factors that contribute to Ca2+ binding by investigating the relationship between net charges
in the coordination sphere and the Ca2+-binding affinities [13, 15]. It is important to mention that
the electrostatic nature of Ca2+ binding is highly affected by charged residues, binding geometry,
and protein environment [59].
Two proteins were designed in order to study the effect of local charges on metal-binding
affinity, CD2.6D15 and CD2.7E15. The first one (CD2.6D15) has three negatively charged
ligands and contains two mutations (N15D and N17D) and two natural residues as ligands (N60
and D62) as it can be observed in the NMR structure of this engineered protein (Figure 55A)
[59]. The second one (CD27E15) has five negatively-charged ligands, three mutations (N15E,
L58D, and K64D) and two natural residues as ligands (E56 and D62) as observed in the model
structure shown in Figure 55B [59]. Previous studies have concluded that the incorporation of
these Ca2+ ligands into the host protein did not reveal global conformational changes in the
designed proteins [59]. It was also concluded that CD2.7E15 had a 12 to 14-fold increase in the
binding affinity for Ca2+, Tb3+, and La3+ compared to CD2.6D15 [59]. However, the localized
charges in CD2.7E15 decreased the host protein’s thermal stability (Tm) from 61 oC to 41 oC
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[59]. The designed approach can be therefore used to further study Ca2+ signaling and binding
affinities properties.

A

B

Figure 55. (A) NMR structure of CD2.6D15. (B) Model structure of CD2.7E15. Pictures
generated using PyMol (DeLano Scientific LLC) [59].
CD2.7E15 was initially expressed in E. coli as a fusion GST-tag protein but its expression
and purification levels were very low. Therefore, in order to improve this protein’s expression
and purification this protein has been expressed and purified as a tag-less protein. Also, a series
of newly-designed proteins have been created using the design approach for the purpose of
creating contrast agents in cancer cell targeting. One of these designed proteins is CD2.7E15.52I
containing a bombesin insertion (Glu-Gln-Arg-Leu-Gly-Asn-Gln-Trp-Ala-Val-Gly-His-LeuMet-NH2). Bombesin possesses a high affinity for the gastrin releasing peptide which is over
expressed on different types of cancer cells [60]. Bombesin addition can therefore enrich the
environment in which the designed protein contrast agent moves and in that way increase the
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intensity and targeting in tumor detection. This protein did not contain a tag and for that reason it
was necessary to develop new and optimized conditions to express and purify tag-less protein.
6.2

Designed proteins as MRI contrast agents
Magnetic resonance imaging (MRI) is a noninvasive technique that provides three-

dimensional images of anatomic structures and that are often used as contrast agents between
healthy and pathological tissues [61, 62]. Gadolinium (Gd3+) chelators are commonly-used
contrast agents and recent studies have determined that CD2.6D15 and CD2.7E15 have a high
affinity for Gd3+ and they can be therefore used as Gd3+ chelators in magnetic resonance imaging
(MRI) [63]. These protein-based MRI contrast agents have shown that metal-binding selectivity
and affinity can be improved by utilizing the design approach [63].
6.3
6.3.1

Results and discussion
CD2.7E15.52I expression optimization
Engineered proteins that were created using a designed approach (CD2.7E15 and variants)

has been previously expressed and purified using affinity chromatography but typically exhibited
a common problem with low yields. Protein purification from inclusion bodies was an excellent
option to further optimize the purification and in that way improve the proteins’ yield at a low
cost. This technique advantageously reduces protein degradation and improves proper refolding
which typically enhances protein’s activity.
CD2.7E15.52insertion (CD2.7E15.52I) was expressed in E. coli as a fusion engineered
protein in a pET20b vector. Initial expression of this protein was attempted using four cell strains
BL21, BL21(DE3), BL21(DE3)pLysS, and tuner(pLacI), but only BL21(DE3)pLysS and
tuner(DE3)pLacI produced expression, with the latter resulting in the best expression. This
protein was subsequently expressed at two temperatures 37 oC and 30 oC overnight in order to
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further optimize CD2.7E15.52I expression. The expression growth curve shows that the cell
culture reached an OD of ~1.5 when it was expressed at 37 oC (8 h expression) and it reached an
OD of ~ 2.0 when it was expressed at 30 oC (16 h expression) (Figure 56A). The SDS gels
(Figure 56B) show that a thicker expression band is observed when the protein is expressed at 30
o

C overnight compared to that observed when the protein was expressed at 37 oC. Therefore,

lower temperatures, such as 30 oC increased the expression level. Tuner(DE3)pLacI is IPTG
dependent and for that reason the IPTG concentration used for induction was also optimized.
The best results were obtained when protein expression was induced with 500 μL IPTG per liter.
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Figure 56. (A) CD2.7E15.52.Insertion growth curve at two different temperatures 37 oC (blue)
30 oC (red). (Vector: pET20b, LB media, tuner(DE3)pLacI). (B) CD2.7E15.52.Insertion
expression in E. coli at 37 oC (left) and 30 oC overnight (right).

86
6.3.2

CD2.7E15.52I purification
This protein was purified using an 8 M urea refolding method followed by ion exchange

chromatography. The purification SDS gels clearly show the refolding process step by step when
the protein was expressed at 30 oC overnight (left) and at 37 oC (right) (Figure 57). The first two
lines in both gels show the pellet (P) and the supernatant (Sup) after the cells were broken using
French Press. It can be observed from the gel (Figure 57) that most of the protein is in the pellet
form. The pellet was washed using a detergent (Titron X-100) in order to remove impurities
present in the pellet, such as cell debris or remains. The following three lanes in each gels show
the pellet and supernatant after the pellet was dissolved in 8 M urea and followed dilution in 4 M
urea. It is evident that the protein was completely solubilized from the pellet to the supernatant
form (Figure 57). This SDS gels also show the supernatant after it was dialyzed in 10 mM TrisHCl buffer, pH 7.4. The purification produced better results when the protein was expressed at
30 oC overnight.
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Figure 57. CD2.7E15.52.Insertion purification using urea refolding method. Protein was
expressed at 30 oC overnight (left). Protein was expressed at 37 oC (right).
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Dialyzed sample was further purified using ion exchange chromatography. Protein
concentration was calculated using the extinction coefficient of CD2.WT (11,700 M-1 cm-1) and
its UV-vis absorbance at 280 nm. The final yield was ~20 mg/L.
6.3.3

CD2.7E15 expression
The same approach used to express CD2.7E15.52I was also implemented to express

CD2.7E15. This protein was successfully expressed as a tag-less protein in E. coli
tuner(DE3)pLacI at 30 oC overnight (Figure 58). The expression level was not as high as that
observed for CD2.7E15.52I but it was enough to obtain pure protein. Another difference was that
this protein expressed unknown proteins besides our targeted protein as a strong dark
background was observed in the expression SDS gel.
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Figure 58. CD2.7E15 expression in E. coli at 30 oC overnight (vector: pET20b, LB media,
tuner(DE3)pLacI).
6.3.4

CD2.7E15 purification
The same approach used to purify CD2.7E15.52I was also implemented to purify

CD2.7E15. The purification was therefore performed using an 8 M urea refolding method
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(Figure 59).The first two lines show the pellet (P) and the supernatant (Sup) after the cells were
broken using French Press. It can be observed (Figure 59) that most of the protein is the pellet
form. The pellet was washed using a detergent (Titron X-100) in order to remove impurities. The
following three lanes in each gels show the pellet and supernatant after the pellet was dissolved
in 8 M urea and then diluted to 4 M urea. It is clear that the protein was completely solubilized
from the pellet to the supernatant form. This SDS gel also shows the supernatant after it was
dialyzed in 10 mM Tris-HCl buffer, pH 7.4. The purity of this protein was not as high as that
observed for CD2.7E15.52I since a series of bands above that of our targeted protein were
observed in the SDS expression and purification gel. Protein was further purified using ion
exchange chromatography after it was dialyzed in 10 mM Tris-HCl buffer. The additional bands
observed in Figure 59 were completely removed after ion exchange FPLC. Figure 60 illustrates
the FPLC profile and SDS gel confirming the high purity of the purified protein.
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Figure 59. CD2.7E15 purification using urea refolding method.
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Figure 60. CD2.7E15 ion exchange chromatography and SDS gel showing the collected relative
fractions from the FPLC.

Protein concentration was calculated using the extinction coefficient of CD2.WT (11,700
M-1 cm-1) and its UV-vis absorbance at 280 nm. The final yield was ~10mg/L.
6.4

Summary
The design approach allows the investigation of local charges and the factors that might

contribute to Ca2+ binding. Two designed engineered proteins CD2.7E15.52I and CD2.7E15
were successfully expressed in E. coli tuner(DE3)pLacI at 30 oC overnight. Tuner(DE3)pLacI
have shown to form a high number of inclusion bodies during protein expression. This cell strain
contains a mutation in lacY (lac permease) gene allowing over protein expression in the presence
of a high IPTG concentration. Over protein expression therefore facilitates inclusion body
formation and sometimes this is the only way to obtain protein. Protein expressed in inclusion
bodies can be purified using refolding methods. These engineered proteins were actually purified
from inclusion bodies utilizing a refolding strategy followed by ion exchange chromatography.
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The final yields were ~20 mg/L for both engineered proteins but further expression and
purification optimization procedures are still under investigation. These designed proteins have
been used as protein-based MRI agents and they have been also used to perform metal-binding
and affinity analyses.
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7.

FINAL CONCLUSIONS AND SIGNIFICANCE OF THIS THESIS

Ca2+ is an essential element in living organisms since it regulates a great number of
biological and cellular signaling pathways. Ca2+ concentrations in extracellular and intracellular
environments are balanced and stabilized by a select group of Ca2+-binding proteins. This vital
group of proteins usually has two or more Ca2+-binding sites that interact with each other upon
Ca2+ binding. They are able to undergo conformational changes upon Ca2+-binding and these
conformational changes are then translated into metabolic pathways. Additionally, they are able
to sense intracellular and/or extracellular Ca2+ concentration changes or imbalances and take
action in order to maintain a proper equilibrium in both environments.
The investigation of Ca2+-binding sites is essential in order to understand the biochemical
properties of Ca2+-binding proteins and further, to comprehend and determine the mechanisms
behind this reciprocal Ca2+-protein interaction. Three approaches have been developed in Dr.
Yang’s laboratory in order to study Ca2+-binding sites located in Ca2+-binding proteins. The
basic principle of these approaches is the prediction of Ca2+-binding sites using computer
algorithms, which provides a rational basis for grafting and/or designing them into host proteins.
In the grafting approach, individual Ca2+-binding sites were inserted into host proteins (e.g. CD2
or EGFP) in order obtain metal-binding affinities and site-specific properties of Ca2+-binding
proteins. In the design approach, site-directed mutagenesis was used to design Ca2+-binding sites
into host proteins. This approach has permitted the investigation of factors that contribute to
local Ca2+-binding and the relationship between net charges located in the coordination sphere of
these sites. In the subdomain approach, Ca2+-binding proteins have been dissected into different
subdomains containing 2-3 Ca2+-binding sites. This approach allowed the study of the interaction
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between Ca2+-binding sites, their conformational changes, and cooperative interaction upon Ca2+
binding.
A variety of techniques (e.g. CD, MS, NMR, metal-binding titrations, and X-ray
crystallography) have been applied in order to test the predicted Ca2+-binding sites and to
understand important properties and characteristics of Ca2+-binding proteins. The techniques
used in these studies require high protein concentration and purity, and that is why expression
and purification of engineered proteins play essential roles to further conduct those experiments.
The chosen expression host for engineered protein production was E. coli. This is the most
widely used bacterial host for protein expression, but sometimes expression and purification of
engineered proteins can be very challenging because the insertion of foreign sequences into a
host protein might result in stability and conformational changes that affect protein yield and
purity. Other challenges include low expression levels, formation of inclusion bodies due to
improper folding, and proteolytic degradation.
In this thesis, the significance of expression and purification of engineered proteins as initial
steps to further investigation of the properties of Ca2+-binding proteins is discussed with respect
to optimization of expression and purification to obtain high protein yield and purity. Logically,
further experimentation is limited by the availability of proteins of sufficient quality and
quantity.
In previous chapters, I have shown that expression and purification of engineered Ca2+binding proteins are highly influenced by a great number of factors, such as expression
temperature, cell strains, vectors, and inducer concentrations. Additionally, there are an extended
number of purification techniques and fusion technologies that can be employed to purify
proteins based on the protein’s physiochemical properties, such as their isoelectric points,
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molecular weights, polarity, and/or affinity to ligands. Thus, purification of engineered proteins
was performed using different techniques depending upon their characteristics.
Proteins engineered using a grafting approach in which an individual Ca2+-binding motif
was inserted into CD2.D1 (CD2-WT, CD2.STIM1, CD2.STIM1.Mut, and CD2.RubCa) were
expressed in E. coli BL21(DE3) at 37 oC and further purified by affinity chromatography since
they contained a GST-tag, followed by ion-exchange chromatography. Additionally, another set
of engineered proteins that had EGFP as the host protein (WT-EGFP and EGFP-172-III-172)
were also expressed in E. coli BL21(DE3) but the expression temperature was reduced to 30 oC
in order to increase chromophore formation. These proteins were purified using affinity
chromatography since they contained a 6x-his-tag. The yields for these proteins were between
20-70 mg/L (Chapter 3).
CaM is an intracellular Ca2+-binding protein that was expressed in E. coli BL21(DE3) at 37
o

C in LB media and at 30 oC overnight in 15N labeled minimal media. A lower temperature was

used for the minimal media because it required a longer incubation time since it contained fewer
nutrients compared to LB media. CaM was purified using a phenyl-sepharose column and
hydrophobic interaction chromatography, since this protein undergoes a conformational change
upon Ca2+ binding that exposes hydrophobic patches to the surface. The final yields were 74.8
mg/L and 57.8 mg/L when the proteins were expressed in LB and

15

N labeled minimal media

respectively. CaM 15N labeled protein was further utilized to perform NMR studies (Chapter 4).
The CaSR is another important Ca2+-binding protein that has been studied. Five Ca2+binding sites in the ECD of this receptor were predicted and two of these sites (3 and 5) were
grafted into CD2.D1. These two sites were also expressed in E. coli BL21(DE3) at 37 oC and
purified using GST-tag affinity and ion exchange chromatography. An additional set of mutants
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were also expressed and purified using the same approaches. The final yields for these proteins
were ~7 mg/L. Metal-binding studies performed by Dr. Huang have determined the metalbinding affinity of these two Ca2+-binding sites (Chapter 5).
A subdomain approach was also utilized to study the CaSR in which the ECD of this
receptor was dissected into three subdomains containing the predicted Ca2+-binding sites. These
proteins presented low expression levels, were highly insoluble, and/or were expressed as
inclusion bodies. We first attempted to optimize the expression and purification of subdomain 1
by utilizing different vectors, E. coli cell strains, and temperatures. Subdomain 1 expression
levels and solubility were highly enhanced when the protein was expressed at 30 oC and when
rosetta(DE3)pLysS was used as the cell strain. These conditions were utilized to express and
purify subdomain 2. Subdomain 3 was expressed in E. coli tuner(DE3)pLysS as inclusion bodies
and they were purified using a refolding technique followed by affinity chromatography. The
final yields were 7-36 mg/L. Additional efforts have been made to express and purify the ECD of
the CaSR. This 73 kDa protein contains ~20 cysteine residues that have highly influenced
protein expression and purification. The best cell strains that expressed this protein were rosettagami(DE3)pLysS and origamiB(DE3)pLysS since these strains contain mutation in thioredoxin
and glutathione reductase genes facilitating disulfide bond formation as well as proper protein
folding. The optimum expression and purification conditions are still under investigation since
the protein presented high levels of degradation and precipitation. Further experiments
performed by Dr. Yun Huang (e.g. CD and trp fluorescence) have shown that a conformational
change is observed when saturating Ca2+ concentrations were added to the proteins.
Additionally, metal-binding studies have shown that subdomain 1 exhibited a biphasic binding
mechanism (Chapter 5).
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Another set of engineered proteins (CD2.7E15 and CD2.7E15.52I) were created utilizing a
design approach in which Ca2+-binding sites were designed in CD2.D1 using site-directed
mutagenesis. These proteins were expressed as tag-less proteins in E. coli tuner(DE3)pLacI as
inclusion bodies and further purified using a refolding strategy followed by ion exchange
chromatography. Protein expression and purification from inclusion bodies might be an efficient
way to obtain active proteins with high yields and purity. CD2.7E15.52I has been used as a MRI
contrast agent for tumor targeting (Chapter 6).
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